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Resumo 
O presente estudo teve como objetivo analisar o efeito de dois protocolos de 
exercício crónico distintos (treino em tapete rolante - TM e atividade física 
voluntária em roda livre - FW) na disfunção mitocondrial induzida pelo 
tratamento sub-crónico de doxorrubicina (DOX), uma potente droga 
antineoplásica bastante eficaz cuja principal limitação é a toxicidade cardíaca. 
Foram utilizados 32 ratos Sprague-Dawley macho jovens divididos em seis 
grupos (n = 6 por grupo): salino sedentário (SAL + SED), salino treinado (SAL + 
TM, 12 semanas de treino em tapete rolante), salino roda-livre (SAL + FW 12 
semanas de atividade física em roda livre), tratado com DOX sedentário (DOX 
+ SED [7 semanas de tratamento sub-crónico de DOX (2mg.kg-1.wk-1)], DOX + 
TM e DOX + FW. Foi analisada a funcionalidade mitocondrial cardíaca in vitro 
[consumo de oxigênio, potencial transmembranar (ΔΨ) e swelling osmótico], 
assim como os níveis de MDA e grupos sulfidril. 
O tratamento com DOX afetou a funcionalidade mitocondrial cardíaca, 
alterando o consumo de oxigénio, o potencial transmembranar assim como o 
swelling osmótico durante a indução do poro de permeabilidade transitória 
mitocondrial (DOX + SED vs SAL + SED). A disfunção induzida pela 
administração de DOX no estado 3, no índice de controlo respiratório, ADP/O, 
no ΔΨ máximo, na repolarização, na lag-phase, amplitude e taxa de swelling, 
assim como no nível de MDA e no conteúdo grupos sulfidril foram revertidos 
pelos dois tipos de exercício crónico. 
Ambos os protocolos de exercício estudados atenuaram a disfunção 
bioenergética das mitocôndrias cardíacas associada ao tratamento sub-crónico 
com DOX. Os nossos resultados são mais um contributo para o estudo dos 
efeitos cardioprotetores do exercício físico realizado antes, durante e após o 
tratamento com DOX, não só na população adulta mas também idosa. 
PALAVRAS-CHAVE: EXERCÍCIO, CORAÇÃO, BIOENERGÉTICA, 
FUNCIONALIDADE MITOCONDRIAL, DOXORRUBICINA.  
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Abstract 
The effects of two distinct chronic exercise models (endurance treadmill training 
– TM and voluntary free-wheel activity - FW) against mitochondrial dysfunction 
induced by sub-chronic treatment of doxorubicin (DOX), a potent antineoplastic 
drug known to induce a dose-related cardiac and mitochondrial toxicity, were 
analyzed. 
Male young Sprague-Dawley rats were divided in six groups (n=6 per group): 
saline sedentary (SAL+SED), saline exercised (SAL+TM; 12-wks treadmill), 
saline freewheel (SAL+FW, 12-wks voluntary free-wheel), DOX+SED [7-wks 
sub-chronic DOX treatment (2mg.kg-1.wk-1)], DOX+TM and DOX+FW. In vitro 
endpoints of heart mitochondrial function [oxygen consumption, membrane 
potential (ΔΨ) and osmotic swelling], MDA level and sulfhydryl groups content 
were evaluated.  
DOX affected mitochondrial function as seen by oxygen consumption, ΔΨ 
endpoints and osmotic swelling during MPTP induction (DOX+SED vs. 
SAL+SED). DOX-induced impairments in state 3, respiratory control ratio, 
ADP/O, maximal ΔΨ, repolarization, ADP lag-phase, swelling amplitude and 
average swelling rate as well MDA level and sulfhydryl groups content were 
reverted by both TM and FW.  
Both studied chronic models of physical exercise reestablished heart 
mitochondrial bioenergetic defects induced by sub-chronic DOX treatment. Our 
results contribute to the analysis of the cardioprotective effects of exercise 
performed before, during and after DOX treatment no only on adult but also in 
older population. 
KEY-WORDS: EXERCISE; HEART; BIOENERGETIC; MITOCHONDRIAL 
FUNCTION; DOXORUBICIN.  
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1. Introduction 
Doxorubicin (DOX, or adriamycin) is a highly effective antibiotic used to treat 
several types of malignancies. Unfortunately, the clinical use of DOX is limited 
by the occurrence of a dose-related cardiac toxicity that results in life-
threatening cardiomyopathy. DOX-induced cardiomyocyte dysfunction is 
associated with increased levels of oxidative damage involving mitochondrial 
bioenergetics collapse in the process (Wallace 2007). Actually, sub-chronic 
DOX treated rats reveal defects on heart mitochondrial function, which are 
accompanied by compromised mitochondrial electron transport chain activity 
and increased oxidative stress and damage (Berthiaume, Oliveira et al. 2005, 
Santos, Moreno et al. 2002).  
Among the strategies advised to counteract the cardiac side effects associated 
with DOX treatment, physical exercise has been studied and recommended as 
a non-pharmacological tool against myocardial injury (Ascensao, Ferreira et al. 
2007, Ascensao, Lumini-Oliveira et al. 2011, Ascensao, Oliveira et al. 2012). 
Previous work has suggested that the advantage of both acute (Ascensao, 
Lumini-Oliveira et al. 2010, Wonders, Hydock et al. 2008) and chronic exercise 
models (Ascensao, Ferreira et al. 2006, Ascensao, Magalhaes et al. 2005, 
Ascensao, Magalhaes et al. 2005, Chicco, Hydock et al. 2006, Chicco, 
Schneider et al. 2005, 2006) on the preconditioning of DOX-treated rats include 
the protection of cardiac tissue and mitochondria against induced impairments. 
Moreover, recent studies investigating the effects of exercise performed during 
and following models of late-onset cardiotoxicity caused by DOX provide 
evidence of exercise-induced cardioprotection in both adult and juvenile rat 
models (Hayward, Lien et al. 2012, Hydock, Lien et al. 2012). However, the 
cellular and molecular mechanisms underlying this protective phenotype 
induced by exercise are still elusive. In particular, whether perturbations in heart 
mitochondrial oxidative phosphorylation capacity and pro-oxidant redox 
modifications associated with cumulative DOX administration are modulated by 
long-term physical exercise performed during and after treatments is yet 
unknown. 
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We therefore aimed to analyze the effects of two types of long-term exercise 
with distinct characteristics, performed before and during the overall DOX 
treatment, on cardiac mitochondrial bioenergetics. Heart mitochondrial 
respiratory parameters associated with oxygen consumption, transmembrane 
electrical potential and osmotic swelling during mitochondrial permeability 
transition pore (MPTP) induction as well as markers of oxidative stress 
(sulfhydryl groups (-SH) and malondialdehyde (MDA) contents) were 
determined. 
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2. State of art 
2.1- Age effects on cardiac function 
Aging can be characterized as a time dependent decline of maximal 
functionality that affects tissues and organs of the whole body (Figueiredo, Mota 
et al. 2008). The average human life span has markedly increased in modern 
society, a fact largely attributed to advances in medical and therapeutic 
sciences that have successfully reduced the severity of several diseased 
conditions (Chaudhary, El-Sikhry et al. 2011). However, elderly individuals 
continue to suffer the greatest burden from cardiovascular disease, including 
coronary heart disease that remains the leading cause of death in industrialized 
countries (Wei 2004). That can be understood as the result of several 
morphophysiological, structural and functional alterations, which we will further 
address in detail (Table 1). 
The aging-induced increase on vascular stiffness, septum and myocardium 
thickness and fibrosis, is associated, among others, with: i) decreased myocyte 
number; ii) increasing cardiomyocyte size with alterations in calcium (Ca2+) 
homeostasis and iii) increased collagen fibers deposition, leading to cardiac 
diastolic dysfunction, increased afterload, and loss of arterial and heart 
compliance (Strait and Lakatta 2012). Importantly, these physiological-related 
impairments along with unchanged cavity size and increased left ventricle 
hypertrophy are the major characteristic of aging heart (Chaudhary, El-Sikhry et 
al. 2011). In fact, Dai et al (2009) reported that aging left ventricle mass index 
increased by around 75% compared to a young adult group, indicating the 
increase prevalence of left ventricular pathological hypertrophy with age. It was 
also reported reduction in diastolic function, as well as worsening of myocardial 
performance index (Dai, Santana et al. 2009). 
Furthermore, the conduction system also undergo some structural alterations 
leading to heart dysfunction, including fat accumulation around sinoatrial node, 
which creates a partial or complete separation of the node from atrial tissue 
(Strait and Lakatta 2012), a marked decreased in peacemakers number cells 
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(Wei 2004) and an increased calcification in conduction system leading 
ultimately to atrioventricular conduction lock. Slow and prolonged systole and 
diastole are other aging-related heart features usually related to an aberrant 
Ca2+ handling (Strait and Lakatta 2012). The decreased diastolic function, which 
falls linearly with aging at a rate of about 6–7% per decade (Gates, Tanaka et 
al. 2003), is associated to a decrease in diastolic filling reported at rest and 
under stress conditions, as some daily tasks that promote an acute increase of 
physical demands. In addition, the degeneration of cardiac valvular apparatus is 
commonly reported, being valvular annular dilation found in the majority of older 
persons and is also associated with concomitant coronary artery calcification 
(Wei 2004).  
 
Table 1. Effects of aging on cardiovascular system 
Morphophysiological 
changes 
Structural Changes Functional Changes Reference 
 
Heart and Vascular system 
   
↓ Cardiomyocytes number 
↑ Cardiomyocytes size 
↑ Collagen deposition 
↑ Fibers deposition 
↓ Cardiomyocytes function 
 
↑ Septum and Myocardium stiffness 
↓ Heart compliance 
↑ Vascular thickness 
↓ Vascular compliance 
↑ Systolic pressure 
↓ Diastolic function 
↓ max heart rate                
↓ max cardiac output         
↑ Afterload 
Prolonged systole and diastole 
 
Hotta and Uchida 
(2010), Reynolds 
(2004), Strait and 
Lakatta (2012), T. 
Shioi (2012), 
Taylor, Cable et al. 
(2004) 
 
Conduction system    
↑ Fibrosis and fat 
accumulation (SA node) 
↓ Peacemakers cells 
number 
↑ Conduction system 
calcification 
 
↓ Ventricular compliance 
  
↑ Heart rhythm disturbances 
↑ Risk atrioventricular conduction lock 
↑ Risk atrial arrhythmias, 
↑ Risk atrial fibrillation 
↑ Risk tachycardia 
↑ Ventricular arrhythmias 
Hotta and Uchida 
(2010), Strait and 
Lakatta (2012) 
 Valvular system   
 
 
↑ Valvular annular dilatation  Coronary artery calcification   Reynolds (2004) 
    
(↑) – increase; (↓) – decrease 
↓ VO2 max 
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Overall, these aging related heart morphophysiological, structural and functional 
alterations result in increased systolic pressure, one major risk factors for 
development of atherosclerosis, hypertension and stroke, and arterial fibrillation 
(North and Sinclair 2012).  
As a consequence of all those age-associated alterations, cardiac function 
declines maximal functionality, being that, under basal conditions this decline 
may not be detected (Wessells and Bodmer 2007). 
The most used standard index of cardiorespiratory fitness is the maximal 
oxygen consumption (VO2max), which declines approximately 10% per decade 
starting at 20 to 30 years old (Souza 2012). VO2max can be estimated by the 
Fick’s equation: 
Equation 1: VO2max=Q×(A-VO2)diff 
Q is cardiac output, and is the product of max heart rate and stroke volume, (A-
VO2)diff is the arteriovenous difference of oxygen. As it is observed in figure 1, 
based on Fick´s equation, aerobic exercise capacity depends on cardiac output 
and arteriovenous difference (Seeley, Stephens et al. 2005). 
Reductions in peak heart rate, peripheral oxygen utilization and stroke volume 
appear to mediate the age-associated decline in VO2max. Actually, impairments 
in cardiac filling and increased afterload leads to a decrease in heart rate, in a 
stress situation (Taylor, Cable et al. 2004) being the major responsible for much 
of the age-associated decrease in maximal cardiac output. Reductions in 
muscle oxygen delivery and therefore (A-VO2)diff are mainly due to reduced 
and maldistribution of cardiac output. Also, a decline in skeletal muscle 
oxidative capacity with aging is reported, due in part to mitochondrial 
dysfunction, which appears to play a particularly important role in old age, 
where skeletal muscle VO2max is observed to decline by approximately 50% 
even under conditions of similar oxygen delivery as young adult muscle (Betik 
and Hepple 2008). 
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Although controversial, some reports suggested that left ventricular systolic 
function remains relatively preserved and without significant alterations in left 
ventricular stroke volume and cardiac output at rest (for refs see Kappagoda 
and Amsterdam 2012, Lakatta 2002, Morley and Reese 1989). However, at 
peak exercise, stroke volume index is reduced in older individuals and is 
thought to be the consequence of age-related reductions in β-adrenergic 
stimulation, increases in vascular stiffness, aortic impedance and impaired left 
ventricular diastolic function (Spina, Turner et al. 1998).  
Generally, the morphophysiological and functional alterations related to 
VO2max decline with aging are depicted in figure 1. 
 
 
Figure 1. Representative scheme of reduced cardiorespiratory fitness (VO2max) in old 
adults. (adapted from Oxenham and Sharpe (2003)). 
 
Studies have demonstrated that advancing age is also associated with 
decreased heart rate variability (O'Brien, O'Hare et al. 1986, Yeragani, 
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Sobolewski et al. 1997). Heart rate variability is a reliable reflection of the many 
physiological factors modulating the normal rhythm of the heart. In fact, it 
provides a powerful mean of observing the interplay between the sympathetic 
and parasympathetic nervous systems and it is thought to reflect the heart’s 
ability to adapt to changing circumstances by detecting and quickly responding 
to unpredictable stimuli (Rajendra Acharya, Paul Joseph et al. 2006). It is 
particularly relevant on daily tasks, as it is important to maintain a normal 
lifestyle without manifestation of heart injury. Also, it has been suggested that a 
decreased responsiveness to β-adrenergic receptor in aged hearts might be 
responsible for decreased heart rate variability in aged people during exercise 
or stress (Chaudhary, El-Sikhry et al. 2011).  
Ischemia-reperfusion (IR) injury is the primary pathological manifestation of 
coronary artery disease (Lennon, Quindry et al. 2004, Powers, Demirel et al. 
1998). The level of IR-induced myocardial injury can range from a small insult, 
resulting in limited damage, to a large insult, culminating in major cardiac 
electrical and mechanical dysfunction and ultimately in death (Powers, Quindry 
et al. 2004). Nowadays, it is well established that numerous age-related cellular 
and functional changes occur in the heart that could lead to ischemia-
reperfusion injury as i) alterations in cardiac gene expression; ii) increased 
oxidative stress and iii) reduced ability of the heart to response to stress 
(Powers, Quindry et al. 2004). In this regard, Starnes et al. (1997) reported that 
immature hearts tolerate and recover from hypoxia better than adult hearts, and 
that the sarcolemmal membranes of immature rat hearts seem to be less 
susceptible to damage from hypoxic stress than those of older group. 
It is notable that throughout life, there are many impairments originating cardiac 
injuries and ultimately death. So, it is important to implement countermeasures 
to attenuate and minimize those consequences, which will enhance old people 
lifestyle and lifespan. Recently, several approaches have been investigated and 
physical activity has been shown to be an important countermeasure to protect 
against myocardial injuries (Ascensao, Ferreira et al. 2007, Kavazis 2009, 
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Kavazis, Alvarez et al. 2009, Powers, Quindry et al. 2004, Starnes and Taylor 
2007).   
Furthermore, among the several mechanisms or causes for cardiac dysfunction, 
mitochondrial abnormalities have a central role (for refs see Braunwald and 
Bristow 2000). In fact, due to the key mechanisms to which these organelles are 
associated such as energy production, ion regulation, pH control, Ca2+ 
homeostasis, redox reactions, control of cell signaling and apoptosis 
mitochondria assume a pivotal role in cellular functioning. For these reasons, 
mitochondria have been suggested as reliable sensors of cellular functionality 
and (dys)functional mitochondria correlates with (dys)functional heart tissue 
submitted to a variety of stimuli, including age (Wallace 2010). 
Because heart is primarily a postmitotic tissue that exhibits a highly aerobic 
metabolism due to the abundance of large mitochondria, a dependence on 
healthy mitochondria for normal organ function is implicated (Judge and 
Leeuwenburgh 2007). 
The following section will address the effects of aging process on the 
modulation of mitochondrial function and related mechanisms. 
 
2.1.1 Aging effects on cardiac mitochondria function 
In metabolically active and thus energy-demanding tissues such as the heart, 
mitochondria, as producers of most of the ATP necessary for metabolism via 
oxidative phosphorylation, have a very important role in the supply of energy for 
continuously contracting myocytes (Ascensão 2011). Additionally, mitochondria 
play other important roles as cellular redox and ion homeostasis, oxygen 
sensing, signaling and regulation of programmed cell death (for refs see 
Rabinovitch 2012, Sheu 2009). Therefore, mitochondrial integrity is vital for 
cellular homeostasis and cardiac performance (Chaudhary, El-Sikhry et al. 
2011) being age-related heart mitochondrial dysfunction closely associated to 
9 
 
life limiting impairments, including congestive heart failure (CHF) (Chaudhary, 
El-Sikhry et al. 2011, Judge and Leeuwenburgh 2007, Pashkow 2011). 
In 1956, Harman et. al, proposed the free radical theory of aging, postulating 
that the production of reactive oxygen species (ROS) is a major determinant of 
lifespan acting  as important mediators responsible for the cellular damage seen 
in aged cells (Harman 1956). Later, it was defined that mitochondria are the 
main source of ROS and the main target of their injury being ROS produced 
within mitochondria almost 90% of the total ROS produced in the cell (Hearman 
1972); so it was postulated as the “key organelles” initiating cellular processes 
leading to death (Chaudhary, El-Sikhry et al. 2011). Indeed, evidences suggest 
that with advanced age, mitochondrial production of ROS significantly increases 
in heart tissue (Judge, Jang et al. 2005), which leads to development of 
degenerative diseases (for refs see Rabinovitch 2012). Within cells, ROS are 
produced in multiple compartments and by multiple enzymes including reduced 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase at the plasma 
membrane, respiratory chain within mitochondria, lipid oxidation within 
peroxisomes and by clyclo-oxygenases and xanthine oxidase in the cytoplasm 
(Dai and Rabinovitch 2009, Dai, Rabinovitch et al. 2012). Although all of these 
source contribute to the overall oxidative damage, mitochondria are one of the 
most contributors for ROS generation as a byproduct of electron transfer during 
oxidative phosphorylation (Dai and Rabinovitch 2009). Most specifically, excess 
electrons from complex I and III can be transferred directly to oxygen (O2) to 
generate superoxide anion (O2-), which is then converted to hydrogen peroxide 
(H2O2) and ultimately into a hydroxyl radical (OH.), the most reactive ROS 
species (Dai and Rabinovitch 2009). The unbalance between ROS production 
and the capacity of antioxidant machinery, favoring ROS production is usually 
called oxidative stress. Mitochondria have antioxidant enzymes that play a vital 
role in the protection against oxidative stress (Meng 2007), being manganese 
superoxide dismutase (MnSOD), catalase (CAT) and glutathione peroxidase 
(GPX) the most commonly cited (Ascensão 2003). In addition, there are non-
enzymatic antioxidant compounds, both endogenous and exogenous, such as 
glutathione (GSH), vitamins C and E, and lipoic acid that play important roles in 
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ROS neutralization or in the attenuation of the effects caused by increased ROS 
production (Ji, Leeuwenburgh et al. 1998). Heat shock proteins (HSPs) are 
another system of cellular defense against oxidative stress (Ascensao, Ferreira 
et al. 2007, Hamilton, Staib et al. 2003, Powers, Locke et al. 2001). These 
“stress-induced proteins” are ubiquitous and highly conserved chaperones, 
important in the folding of new synthesized, damaged or transported proteins. 
Moreover, HSPs mediate mitochondrial protection against oxidative stress, 
namely HSP70 have been associated with myocardial protection (Gunduz, 
Senturk et al. 2004).  
To understand the impact of oxidative stress, which is known to damage 
proteins, lipids, and deoxyribonucleic acid (DNA) (Shioi and Inuzuka 2012), 
some oxidative markers are analyzed in mitochondria as carbonil groups 
(protein oxidation), malondialdehyde (MDA) (lipid peroxidation marker) or 
thiobarbituric acid reactive substances (TBARS) (nonspecific marker for lipid 
peroxidation), among others. The accumulation of oxidant-induced damage in 
mitochondria may be a major contributing factor to the age-related alterations in 
myocardial function (Chen and Knowlton 2011, Ljubicic, Menzies et al. 2010, 
Pohjoismaki, Boettger et al. 2012). Nonetheless, some authors have suggested 
that throughout the aging process, the antioxidant capacity can be adjusted in 
response to prooxidant exposure (Ji, Leeuwenburgh et al. 1998). Localized 
oxidative stress in specific organs, tissues, and organelles may stimulate 
cellular uptake and synthesis of certain antioxidants under complicated genetic, 
hormonal, and nutritional regulation (Harris 1992). One possibility is that aged 
mitochondria produce more ROS stimulating antioxidant enzyme gene 
expression. This scenario is consistent with the finding that mitochondrial 
antioxidant enzyme activity showed a greater increase in the senescent 
myocardium (Ji 1993, Ji, Dillon et al. 1991, Rao, Xia et al. 1990, Vertechy, 
Cooper et al. 1989). Nevertheless, data seems to be controversial as no 
alteration (Bejma, Ramires et al. 2000, Tian, Cai et al. 1998) or decrease in 
antioxidant activity (Bagchi, Bagchi et al. 1996, Pritsos and Ma 2000) have also 
been reported. So, increased antioxidant activity may be interpreted as being 
beneficial because it provides better protection against oxidant-induced 
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damage, or it may be viewed as negative because it could indicate a need for 
enhanced antioxidant defenses due to increased oxidant production (Beckman 
and Ames 1998).   
However, characterization of age-related changes in cardiac mitochondria has 
been challenged due to the fact there are two distinct populations of 
mitochondria in the myocardium (Fannin, Lesnefsky et al. 1999). 
Subsarcolemmal mitochondria (SSM) are located beneath the plasma 
membrane, whereas interfibrillar mitochondria (IFM) are found in parallel rows 
between the myofibrils. There are important biochemical and functional 
differences between SSM and IFM and it has been revealed that IFM are more 
adversely affected with age (Fannin, Lesnefsky et al. 1999, Judge, Jang et al. 
2005), although Judge et al. (2007) suggests that further studies are required to 
determine the mechanisms contributing to these changes, and to further 
characterize differential effects of age upon the SSM and IFM populations in the 
heart. 
Despite this fact, some authors report increased H2O2 production from SSM, but 
not IFM, with age (Judge, Jang et al. 2005, Judge and Leeuwenburgh 2007). 
This can be a consequence of the lower antioxidant capacity on this 
subpopulation. Actually, whereas IFM MnSOD, GPX and CAT levels seem to 
increase with age, in SSM only MnSOD and GPX, but not with CAT, seems to 
be positively regulated. However, as MnSOD converts O2- radicals to H2O2, 
increased MnSOD activity might also represent higher levels of H2O2. Also, 
lower glutathione levels and increased oxidative damage have been suggested, 
supporting that oxidant production within the matrix of “old” IFM is greater than 
that in “young” IFM (Judge, Jang et al. 2005). Similarly, state 3 respiratory rates 
were also lower in “old” IFM. This has a particular concern because IFM are 
likely the major source of ATP production for myosin ATPase (Judge, Jang et 
al. 2005). Because high levels of ATP are required for both systolic contraction 
and diastolic relaxation, reduced availability of ATP as a result of IFM 
dysfunction could contribute to the alterations in cardiac contractility observed 
with age (Judge, Jang et al. 2005). 
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Besides nucleus, mitochondria are the only organelles in animal cells that 
possess their own DNA, the mtDNA, as well as related transcriptional and 
translational synthesis machinery. mtDNA is localized in matrix with physical 
proximity to the mitochondrial respiratory chain (Bratic and Trifunovic 2010).  
However, mitochondria cannot be synthesized de novo, instead they replicate in 
the cytosolic compartment through a process of division (for refs see 
Chaudhary, El-Sikhry et al. 2011). Importantly, the proteins that are encoded by 
mtDNA are vital for normal mitochondrial function and mtDNA does not have 
the protein protection as nuclear DNA and has less effective repair mechanisms 
(Desler, Marcker et al. 2011). Therefore, mutations in mtDNA through oxidative 
stress affect the expression and integrity of oxidative phosphorylation 
complexes and can cause mitochondrial dysfunction and increased ROS 
production (Wallace 2010). So, it is notable the interrelationship between 
oxidative phosphorylation complexes, ROS levels, mtDNA mutations and 
ultimately cell death. Furthermore, mutations in mtDNA and the resultant 
decline in mitochondrial activity observed in aged tissues are responsible for the 
increased generation of ROS, which in turn, will further negatively impact 
mitochondria causing further mtDNA damage. This “vicious cycle” concept 
postulated that accumulation of mtDNA mutations is exponential and associated 
with massive increase in ROS production (Lenaz 1998).  
Being mitochondria strategic organelles essential for cell function and 
homeostasis, providing energy to the cell (Chaudhary, El-Sikhry et al. 2011), 
they must undergo some dynamic mechanisms. Mitochondrial turnover and 
death can occur via several processes that are suggested to be interrelated 
namely  apoptosis, necrosis, autophagy and related dynamics of organelles. In 
this dynamic network biogenesis, fusion and fission are closely associated 
mechanisms (Chen and Knowlton 2011).  
In fact, apoptosis is mediated by two pathways: the extrinsic and the intrinsic 
pathways, and both have been described in cardiac myocytes (Whelan, 
Kaplinskiy et al. 2010). The extrinsic apoptotic pathway can be triggered by Fas 
ligand or tumor necrosis factor (TNF)-α, which are expressed in cardiac 
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myocytes and have been implicated in cardiovascular pathology (Whelan, 
Kaplinskiy et al. 2010). 
Intrinsic pathways involve the participation of endoplasmic reticulum (ER) 
and/or mitochondria (Kroemer, Galluzzi et al. 2007). Impairment in 
mitochondrial integrity, dynamics or metabolic activity may result in a range of 
deleterious effects to the cell, such as reduced ATP production, elevated 
cytosolic Ca2+, increased ROS release, release of proapoptotic factors as 
cytocrome c or caspases activation and Bax translocation, triggering cell death 
(Chen and Knowlton 2011). In mammalian cells, apoptosis is regulated by a 
variety of factors that are essentially either pro-life or pro-death (Goldspink, 
Burniston et al. 2003). Quantitation of the expression of genes involved in the 
apoptotic pathway might represent a good index of the probability for a cell to 
undergo apoptosis. As the number of Bax-expressing cells dramatically 
increases in left ventricular hypertrophy and left ventricular dysfunction 
(Condorelli, Morisco et al. 1999, Green and Reed 1998), it is suggested that 
mitochondrion is the primary organelle mediating the intrinsic apoptotic pathway 
in these conditions (Chiong, Wang et al. 2011) 
Also, if excessive Ca2+ enters to mitochondria and enhanced oxidative stress 
conditions are present, a phenomenon known as permeability transition may 
occur (Ascensao, Lumini-Oliveira et al. 2011). The mitochondrial permeability 
transition is characterized by the loss of the impermeability of the mitochondrial 
membranes and it is suggested that this condition is mediated by the formation 
and opening of protein complex-like pores in the inner mitochondrial membrane, 
the mitochondrial permeability transition pore (MPTP) (for refs see Ascensao, 
Lumini-Oliveira et al. 2011). Increased pro-oxidant generation causing oxidative 
stress is one condition that augmented the susceptibility for the opening of 
these pores and the release of pro-apoptotic proteins within mitochondria as 
cytochrome c, SMAC/DIABLO and the apoptosis inducing factor (AIF), which 
will activate the caspase-related apoptotic pathways. It is suggested that the 
release of these proteins is dependent on the formation and opening of MPTP 
that cross the inner and the outer membranes leading to the loss of 
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mitochondrial membrane potential (Δᴪ), increased mitochondrial osmotic 
swelling and rupture of the outer mitochondrial membrane, which leads to death 
(Ascensao, Lumini-Oliveira et al. 2011). It is believed that the structure and 
regulation of this multi-protein complex comprises the outer membrane voltage-
dependent anion channel (VDAC) as well as the inner membrane adenine 
nucleotide translocator (ANT) and cyclophilin D (Cyc D). Myocyte loss has been 
shown to occur in the aged rat heart and to precede the occurrence of 
ventricular dysfunction (Anversa, Hiler et al. 1986), being apoptotic 
cardiomyocyte death present under different conditions in humans (Haunstetter 
and Izumo 1998, Narula, Haider et al. 1996, Olivetti, Abbi et al. 1997).  
Among the excess of biological phenomena affected by aging, the malfunction 
and decrease of biogenesis of mitochondrial biogenesis seems to exert some of 
the most potent effects on the organism (Lopez-Lluch, Irusta et al. 2008). If 
biogenesis is affected, it is reasonable to expect that mitochondrial turnover 
must be slower and the accumulation of modified lipids, proteins and DNA must 
also increase, further aggravating the conditions resulting on deficient activity of 
aged mitochondria (Lopez-Lluch, Irusta et al. 2008). The precise reason for the 
decrease in the rate of mitochondrial biogenesis during aging is currently 
unknown. However, it seems that both, extra- and intra-cellular regulatory 
factors of mitochondrial biogenesis are implicated. Specifically, peroxisome 
proliferator-activated receptor gamma coactivator (PGC1-α) has been shown to 
act as a common intracellular mediator during mitochondrial biogenesis induced 
by hormonal factors (Weitzel, Iwen et al. 2003), and adenosine 
monophosphate-activated protein kinase (AMPK) an intracellular regulator of 
mitochondrial biogenesis, which activity appears to be one of the main factors 
associated with deficient mitochondrial biogenesis (Reznick, Zong et al. 2007). 
PGC family members have gained particular interest because of their ability to 
drive virtually all mechanisms of mitochondrial biogenesis in the heart, including 
mitochondrial number, mitochondrial respiration, expression of oxidative 
phosphorylation and fatty acids oxidation genes, and ROS levels (Lehman, 
Barger et al. 2000). Decreased PGC-1α expression has been linked to the 
development of heart failure in mouse models (for refs see Moslehi, DePinho et 
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al. 2012), and decline in mitochondrial biogenesis and mitochondrial protein 
quality control in cardiac muscle was found in aging (Koltai, Hart et al. 2012) 
In addition, its well known that mitochondria are dynamic organelles that 
constantly undergo fission and fusion and it has been found to be vibrant 
organelles that continuously divide and fuse within the cell and have functions 
extending beyond energy production, including cell signaling (Liesa, Palacin et 
al. 2009). Disruption of fission and/or fusion can also lead to cellular dysfunction 
and to apoptosis. This dynamic mechanism is regulated by proteins controlling 
fission, such as hFis1 and Drp1, and fusion, such as mitofusin 1 and 2 (MFN1 
and MFN2) and OPA1. The correct function of these proteins seems to be 
critical for normal mitochondrial activity, and their deregulation is associated 
with several pathologic conditions (Lopez-Lluch, Irusta et al. 2008). Indeed, the 
impairments on fission-related protein hFis1 has been associated with the 
process of senescence in mammalian cell cultures (Lee, Jeong et al. 2007). 
Moreover, depletion of hFis1 by RNA interference (RNAi) induces dramatic 
changes in mitochondrial structure, including the enlargement and flattening of 
the organelle. Futrthermore, elimination of any of the mitochondrial fusion 
proteins as MFN1, MFN2 or OPA1, induces mitochondrial fragmentation, as 
expected, being that down-regulation of Opa1 expression in cells by RNAi 
results in spontaneous apoptosis (for refs see Chen and Knowlton 2011). 
Overall, defects in the mitochondrial fission/fusion machinery and so loss of the 
symmetry between fusion and fission (Hoppins, Edlich et al. 2011) may 
contribute to the decline in mitochondrial function during aging. However, 
several fundamental questions remain to be answered (Bossy-Wetzel, Barsoum 
et al. 2003). 
In the next section, the roles of physical exercise as a strategy to improve 
cardiac function in adult and old subjects as well as the mitochondrial-mediated 
mechanisms associated with exercise-induced cardioprotection will be 
addressed. 
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2.2. Exercise and cardioprotection 
Cardiac damage is a major contributor to morbidity and mortality in 
industrialized countries; so it becomes important to develop strategies that 
result in cardioprotective phenotype. In this regard, several approaches have 
been investigated and physical activity has been shown to be an important 
countermeasure to protect against myocardial injuries (Bowles, Farrar et al. 
1992, Harris and Starnes 2001, Powers, Demirel et al. 1998, Powers, Quindry 
et al. 2004). In fact, cardiorespiratory fitness is inversely related to 
cardiovascular and all-cause mortality and it has crucial role preventing heart 
injury (Kokkinos, Myers et al. 2010). Some reports had postulated exercise-
induced benefits based on decreases of some risk factors to develop cardiac 
and myocardium impairments such as bodymass index, body weight, waist 
circumference, abdominal and visceral fat and consequently insulin resistance, 
triglyceride levels, blood pressure and, in general, metabolic syndrome-related 
parameters (for refs see Golbidi and Laher 2012). Therefore, chronic aerobic 
exercise is able, not only, to improve cardiovascular function in young healthy 
subjects, but also, and most importantly, in older people and those with 
cardiovascular risk factors (Hambrecht, Fiehn et al. 1998).  
The study of the mechanisms responsible for exercise-induced cardioprotection 
has been ongoing for over decades and morphological and 
biochemical/molecular alterations have been considered as putative 
mechanisms of exercise-induced cardioprotection. Those include morphological 
adaptations of heart and coronary arteries, induction of myocardial HSPs, 
increased myocardial cyclooxygenase-2 activity, elevated ER stress proteins, 
nitric oxide production, improved function of sarcolemmal and/or mitochondrial 
adenosine triphosphate (ATP)-sensitive potassium channels and increased 
myocardial antioxidant capacity (for refs see Kavazis 2009).  
For instance, exercise induces vascular remodeling and so, morphological 
alterations in coronary arteries through angiogenesis and arteriogenesis 
(Leung, Yung et al. 2008). Here, nitric oxide (NO) assumes important roles due 
its anti-inflammatory, vasodilator and platelet inhibitory effects (Landmesser and 
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Drexler 2005). Also, NO protects against inschemia-reprefusion (IR) injury in 
such a way that the heart responds to ischemia using nitric oxide species in a 
harmonized manner and these mechanisms could be based on inhibition of 
Ca2+ influx into myocytes, antagonism of β-adrenegic stimulation, reduction in 
cardiac oxygen consumption and ability to increase the expression of HSP70 
(for refs see Golbidi and Laher 2011). HSPs protect cell against oxidative injury 
and apoptosis (Polla, Kantengwa et al. 1996) and furthermore, enhance 
recovery from acute myocardial cellular injury protecting heart for subsequent 
injury (for refs see Powers, Locke et al. 2001) by promoting restoration of 
dysfunctional enzymes and preventing aggregation of severely denatured 
proteins. The majority of evidences indicate that members of the 70-kDa family 
are the cytoprotective proteins most responsible for cell protection (for refs see 
Powers, Locke et al. 2001). The expression of HSP70 in cardiomyocytes is 
associated with increased cell survival and protection against ischemic damage 
and its now well established that acute and chronic exercise are able to induce 
increases in the expression of HSP70 (Kregel and Moseley 1996, Powers, 
Demirel et al. 1998), although in a temperature-dependent “fashion”. 
The improved function of sarcolemmal ATP sensitive potassium channels 
(Powers, Quindry et al. 2008) and elevated ER stress proteins are other 
important exercise-induced cardioprotection-related alterations and both have 
special relevance during a cardiac insult (Golbidi and Laher 2012). The ER 
stress proteins help cellular homeostasis by maintaining intracellular Ca2+ 
regulation and protein folding during IR injury (Logue, Gustafsson et al. 2005).  
Considering the importance of mitochondrial machinery in the maintenance of 
cardiac function, mitochondrial-mediated mechanisms have also been 
associated with exercise induced cardioprotection phenomenon. This topic will 
be further discussed in the next sections. 
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2.2.1 Exercise and cardiac mitochondrial adaptations 
As previously mentioned, mitochondrial adaptations may play a critical role in 
exercise-induced protection against cardiovascular impairments. The 
mechanisms behind this phenomenon remain unclear, however it may be 
related to morphological and biochemical adaptations including biogenesis, 
antioxidant production or resistance to cell death pathways (Ascensao, Ferreira 
et al. 2007, Kavazis, Alvarez et al. 2009, Kavazis, McClung et al. 2008). Those 
will be briefly addressed in the following section.  
 
2.2.1.1. Morphological and biochemical adaptations 
Heart is a highly oxidative organ, with a low rate of cell growth and slow 
turnover of proteins; so, it would be expected that heart might have a limited 
ability to adapt to acute and/or chronic conditions.  
Although there are scarcely addressed outcomes about exercise-induced 
cardiac mitochondrial morphological adaptations in healthy hearts, the same 
cannot be stated regarding hearts under deleterious conditions. In fact, under 
deleterious conditions as DOX treatment, diabetes, or aging, morphological 
impairments on heart mitochondria have been reported (Ascensao, Oliveira et 
al. 2012, Searls, Smirnova et al. 2004). Despite this fact, in a study where 
trained animals were submitted to an endurance swimming training program, 
while the non-trained were not engaged in any exercise program Ascensao et 
al. (2006) reported that endurance swimming training per se caused notable 
changes in myocardial structure seen as an apparent increased glycogen 
content, intercalated discs showing a notorious scalloped appearance and 
evident signs of mitochondria biogenesis with elevated number of encroached 
mitochondria per fiber area, probably resulting in an increased volume/density 
of mitochondria. Also, mitochondria division, mild and focal loss of cristae 
density and organization as minimal degradation by-products, were also present 
in non-treated trained hearts. Another study developed by Searls et al. (2004) 
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with type I diabetes rats found in type I diabetes rats that 9 weeks of moderate 
exercise is able to reverse some of the phenotype of diabetic cardiomyopathy. 
Specifically, the mitochondrial quality, cytoplasmic area, and collagen cross-
sectional area returned toward non-diabetic values with exercise. 
Mitochondrial biochemical adaptations to exercise were also reported and 
several approaches have been trying to prove the exercise-induced 
modifications of some parameters involved in mitochondrial bioenergetics. 
Judge et al. (2005) reported that wheel running had no effect on mitochondrial 
protein yield, rates of oxygen consumption (states 4 and 3) or RCR. This was 
not entirely surprising given that other studies have shown that, unlike skeletal 
muscle, oxidative capacity of cardiac muscle is not increased in response to 
treadmill training, an exercise protocol that is typically much more intense than 
voluntary wheel running (for refs see Judge, Jang et al. 2005). Also, Starnes et 
al. (2007) reported that endurance training has no impact on mitochondrial 
oxidative phosphorylation, being that all oxidative phosphorylation parameters 
were similar in endurance trained and sedentary rats. Because the heart is 
highly oxidative, it is not expected to be as responsive to exercise-induced 
increases in oxidative capacity as skeletal muscle. Although, several reports 
suggested that exercise per se is able to improve mitochondrial protein yield, 
rates of oxygen consumption as well as cardiac function (for refs see Ascensao, 
Ferreira et al. 2007, Ascensao, Magalhaes et al. 2006, Chicco, Schneider et al. 
2006, Powers, Lennon et al. 2002). Moreover, Kavasis et al. (2009) reported 
that the abundance of several proteins involved in bioenergetics was altered 
following endurance exercise in both SS and IMF mitochondria. Most 
specifically, the protein levels of several proteins involved in β-oxidation of fatty 
acids were increased following repeated bouts of endurance exercise. It is of 
especial concern as during the development of heart disease or genetic defects 
in mitochondrial fatty acid β-oxidation the myocardial energy source switches 
from fatty acid β-oxidation to glycolysis. Also, there are some controversial 
reports about endurance exercise benefits against Ca2+-induced mitochondrial 
dysfunction. In fact, while Starnes et al. (2007) found that endurance exercise 
training had no influence when mitochondria was challenged with identical Ca2+ 
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concentrations, being that mitochondria from trained and sedentary animals 
displayed similar declines in ATP production, French et al. (2008) found that 
exercise-induced protection against IR injury, in part, by attenuating IR-induced 
oxidative modification of important Ca2+-handling proteins and preventing 
subsequent calpain activation. In this study, MnSOD may had an important role 
as, the results support that exercise-induced increases in myocardial MnSOD 
activity attenuate the oxidation and degradation of Ca2+-handling proteins, 
preventing calpain activation during IR. It has special concern because calpain 
activation within the myocardium has been directly linked with IR-induced 
necrotic and apoptotic cardiac myocyte death (French, Hamilton et al. 2008).  
Furthermore, several reports suggest that exercise per se is able to enhance 
cardiac mitochondria Ca2+ uptake capacity without MPTP induction (Ascensao, 
Lumini-Oliveira et al. 2011, Kavazis, McClung et al. 2008, Marcil, Bourduas et 
al. 2006). Therefore, exercise may induce beneficial morphological and 
biochemical adaptations in mitochondria, which can be translated in a cardiac 
phenotype more functional and protected against deleterious stimuli.  
 
2.2.1.2. Mitochondrial biogenesis 
Due to the high-energy demand of the heart, a decline in mitochondrial function 
can result in a deterioration of cardiac performance (Li, Muhlfeld et al. 2011) 
and can lead to a wide variety of pathophysiological conditions. According to 
some reports, the malfunction of mitochondria and the decrease of 
mitochondrial biogenesis, together with increased oxidative damage, seem to 
exert some of the most deleterious effects on the organism (Guarente 2008, 
Lopez-Lluch, Irusta et al. 2008). Fortunately, although controversial, heart 
seems to have the ability to alter some gene expression profile and phenotype 
to produce new and more functional mitochondria (Lee and Wei 2007). Regular 
exercise or increased energy demand are important stimuli that lead to 
increased mitochondria biogenesis (for refs see Lopez-Lluch, Irusta et al. 2008). 
In fact, increases in cytosolic Ca2+ levels induced by exercise stimulates 
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calmodulin kinase which then promotes PGC1-α expression (Wu, Kanatous et 
al. 2002) that has been shown to be a major regulator of mitochondrial 
biogenesis (Rodgers, Lerin et al. 2005). Also, Geng et al. (2010) showed that in 
skeletal muscle-specific PGC-1α knockout mice, exercise-induced mitochondrial 
biogenesis and angiogenesis were significantly attenuated. However, exercise-
induced mitochondrial biogenesis on cardiac muscle is still not fully illusive. In 
fact, although a significant amount of experimental data on mechanisms 
involved in exercise-induced mitochondrial biogenesis has been obtained in 
skeletal muscle, less information is available about the heart. In this regard, Li 
et al. (2011) reported no changes in mitochondrial biogenesis on left ventricle 
after 3 months of endurance exercise. Actually, in contrast to skeletal muscle in 
which adaptive changes in volume fraction of mitochondria can readily occur, 
this is not so frequent in cardiac muscle (Hood, Balaban et al. 1994). So, the 
exercise-induced benefits on heart mitochondria biogenesis are still 
controversial. 
 
2.2.1.3. Oxidative stress and antioxidant capacity 
With exercise performance, increased O2 consumption creates favorable 
conditions for increased generation of ROS, an inevitable consequence that 
may increase oxidative stress at the organelle, cell, and tissue (Ji, 
Leeuwenburgh et al. 1998). However, if these stimuli are repeated over time, it 
may have a strong modulating effect on various defense systems in cardiac 
cells (Powers, Lennon et al. 2002). Also, in some deleterious conditions that 
lead to ROS production, as IR-induced myocardial injury, DOX administration or 
aging, physical exercise as been reported to induce benefic countermeasures. 
In fact, IR-induced myocardial injury is manifested due to the complex 
interaction of numerous factors but ROS generated by mitochondria during IR 
injury are believed to play key role in this process (for refs see Honda, Korge et 
al. 2005). During IR, mitochondrial ROS generation can lead to increased 
general oxidative stress and consequently Ca2+ overload, which could be of 
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special concern due its close relation with MPTP opening (Ascensao, Lumini-
Oliveira et al. 2011), resulting in the release of proapoptotic proteins and 
subsequent activation of programmed cell death (Adhihetty, Ljubicic et al. 
2007). Also, an additional production of ROS has been related with aging 
process and it has been also reported that ROS expression is upregulated 
during cardiac hypertrophy and heart failure (Gustafsson and Gottlieb 2009), 
being that, increased mitochondrial oxidant production is accepted as a cause 
of myocardial cell loss via apoptosis and necrosis (Judge, Jang et al. 2005). In 
this regard, exercise has been shown to provide intrinsic protection (Bowles, 
Farrar, & Starnes, 1992; M. B. Harris & Starnes, 2001; Powers et al., 1998; 
Powers et al., 2004) and mitochondria play an important role on this 
cardioprotective phenotype (Bejma, Ramires et al. 2000, Zhu, Zuo et al. 2007). 
In fact, the decreased mitochondrial oxidant damage (Judge, Jang et al. 2005) 
is an important adaptive strategy within mitochondria that contribute to 
cardioprotection. 
Decreased oxidant damage can be understood as a result of both reduction of 
oxidant production or increased of antioxidant enzymes. Several reports had 
postulate that chronic endurance exercise results in a reduction of mitochondrial 
oxidant production (Judge, Jang et al. 2005, Starnes, Barnes et al. 2007) and 
enhanced mitochondrial antioxidant enzyme activity (Judge, Jang et al. 2005, 
Kavazis, McClung et al. 2008, Starnes, Barnes et al. 2007) which could reduce 
oxidative stress induced by different stress stimulators (Ascensao, Magalhaes 
et al. 2006, Lennon, Quindry et al. 2004, Powers, Locke et al. 2001). In general, 
most studies designed to investigate the influence of regular exercise on 
cardiac antioxidant activity focus on endurance training programs, and there are 
little available reports on the effect of sprint training in the modulation of 
antioxidant defenses (for refs see Ascensao, Ferreira et al. 2007). However, it 
seems clear that cardiac muscle tissue, when stimulated by acute exercise, 
reveals increased signs of cell damage due to oxidative stress. Despite this fact, 
Ascensao et al. (2011) reveal that a single bout of exercise increased SOD 
activity, and so, decreased oxidative stress. 
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As previous described, GPX, SOD and CAT are included on primary enzymatic 
antioxidant defenses and the relation of those with exercise has been hardly 
studied. Interestingly, current data have reported increases (Lennon, Quindry et 
al. 2004, Powers, Demirel et al. 1998), no changes (Ascensao, Magalhaes et al. 
2005), or even decreases (Chicco, Schneider et al. 2005, Hong and Johnson 
1995) in those antioxidant enzyme activities following endurance exercise 
training. These differences can be a consequence of some methodological 
differences, as characteristics of the animals and/or training protocols; 
biochemical procedures or type of markers and enzymes considered 
(Ascensao, Ferreira et al. 2007). However, the general approaches indicate that 
chronic exercise is responsible for either improved or unchanged levels of 
antioxidant enzymes activity. 
Also, lipid peroxidation and protein oxidation following endurance training had 
been hardly studied and results are still controversial. In fact, both heart lipid 
peroxidation and protein oxidation have demonstrated increases (Aydin, Ince et 
al. 2007), no changes (Ascensao, Magalhaes et al. 2005, Chicco, Schneider et 
al. 2005) or decreases (Ascensao, Magalhaes et al. 2005) in response to 
endurance training. However, major tendencies may be indicative that, in 
general, endurance exercise training has some positive modulator effects on 
some enzymatic and non-enzymatic antioxidant systems (for refs see 
Ascensao, Ferreira et al. 2007).  In addition, the rate of H2O2 production during 
exercise performance has been studied, in order to analyze oxidative stress. 
Judge et al. (2005) showed that exercise could decrease H2O2 production in 
myocardial mitochondria of male rats. More recently, Starnes at al. (2007) also 
reported a H2O2 decrease following an endurance exercise protocol. 
Importantly, they found similar decreases in both IFM and SSM mitochondrial 
populations. However, different results are under apparently conflict since 
Marcil et al. (2006) did not find differences on H2O2 levels following an 
endurance exercise protocol. It is possible that differences in sex or rat strain 
are responsible for the different results (Starnes, Barnes et al. 2007). However, 
it is generally accepted that endurance training induces adaptations within 
myocardial mitochondria, resulting in a decreased oxidative stress. 
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Furthermore, Navarro et al. (2004) reported that moderate treadmill exercise 
significantly decreased the aging-associated development of heart oxidative 
stress preventing the increase in protein carbonyls and TBARS contents of 
submitochondrial membranes and the decrease in antioxidant enzyme 
activities.  
In general, it is accepted that endurance exercise induces cardioprotection 
against oxidative stress possible through an increased antioxidant enzyme 
activity and/or decreased oxidant production.  
 
2.2.1.4. Cell death pathways 
As reviewed in previous sections, apoptosis is one of the pathways of cell death 
and it is also the most studied phenomenon in which exercise induces 
protection. Kavazis et al. (2008) reported that exercise induces a cardiac 
mitochondrial phenotype that resists to apoptotic stimuli in both SSM and IMF. 
In this study, cytochrome c was described with primary role in oxidative 
adaptation within mitochondria and following an exercise training protocol 
cytochrome c release susceptibility after ROS challenge was decreased. Also, 
Cyc D and ANT levels decreased following exercise training, being that, ANT 
decreased in both SSM and IMF. Furthermore, exercise induces increased 
antioxidant (Ascensao, Ferreira et al. 2007, Powers, Locke et al. 2001) and 
exercise is related to attenuation of the oxidation and degradation of Ca2+-
handling proteins, which can lead to caspase-3 and -9 activation, and 
prevention of calpain activation (French, Hamilton et al. 2008). These reports 
suggest that both subfractions of mitochondria undergo biochemical adaptations 
in response to endurance exercise leading to decreased apoptotic susceptibility.  
In addition to IR, the cardiomyopathy-related to and STZ-induced type I 
diabetes and aging, the chronic endurance exercise also provide protection 
against tissue and mitochondrial deleterious effects of DOX treatment, a topic of 
special interest in the present dissertation. In the following section, the 
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mechanisms and consequences of the selective toxicity of this anti-cancer drug 
for the heart will be addressed. 
 
2.3. Doxorubicin: therapeutic agent vs. cardiotoxicity 
One of the mostly used chemotherapeutic drugs is the highly effective 
anthracycline DOX. However, its clinical use is limited by the dose-related and 
cumulative cardiotoxicity and consequent dysfunction that can lead to apoptosis 
(Ascensao, Magalhaes et al. 2005, Carvalho, Santos et al. 2009, Wallace 
2003). In fact, DOX is an anthracycline prescribed alone or in combination with 
other chemotherapeutics for the treatment of various neoplasms such as 
leukemias, lymphomas, thyroid and lung carcinomas, several sarcomas, 
stomach, breast, bone and ovarian cancers (Wallace 2003). It has been shown 
that DOX antineoplastic activity is attributed to its ability to intercalate into the 
DNA double helix and/or to bind covalently to proteins involved in DNA 
replication and transcription, leading ultimately to cellular death through the 
inhibition of DNA, ribonucleic acid (RNA) and protein synthesis (Carvalho, 
Santos et al. 2009). More specifically, DOX can be classified as a 
topoisomerase II poison (Fortune and Osheroff 2000). Topoisomerase II is an 
essential enzyme that plays a role in virtually every cellular DNA process and as 
a result of this action DOX generate high levels of enzyme-mediated breaks in 
the genetic material of treated cells and ultimately trigger cell death pathways 
(Fortune and Osheroff 2000). It has been shown that DOX, by simple diffusion, 
enters cancer cells and binds with high affinity to a proteasome in cytoplasm 
forming a DOX proteasome complex that translocates into the nucleus in an 
ATP-dependent process facilitated by nuclear localization signals. Finally, DOX 
dissociates from the proteasome and binds to DNA due to its higher affinity for 
DNA than for the proteasome (Kiyomiya, Matsuo et al. 2001). This process is 
pictured on figure 2.  
 
26 
 
 
Figure 2. Mechanisms of DOX action and toxicity (adapted from Carvalho, Santos et al. 
2009). 
 
Unfortunately, the clinical use of DOX is limited due the occurrence of a 
multidirectional cytotoxic effects, being cardiotoxicity the most known 
(Berthiaume and Wallace 2007, Sardao, Pereira et al. 2008). Actually, the 
clinical use of DOX soon proved to be hampered by serious problems such as 
the development of resistance in tumor cells or toxicity in healthy tissues and 
heart seems to be a particularly susceptible organ to DOX-induced toxicity 
(Carvalho, Santos et al. 2009). Several mechanisms, in which mitochondria are 
involved, are proposed to be responsible for the increased heart sensitivity to 
DOX-induced toxicity including: i) a special affinity of DOX by cardiolipin, which 
is a major phospholipid component of the inner mitochondrial membrane in the 
heart; ii) a higher mitochondrial density per unit volume in cardiomyocytes when 
compared to other tissues; iii) the possible but controversial existence of a 
specific and external reduced nicotinamide adenine dinucleotide (NADH) 
dehydrogenase able to initiate DOX redox cycling and, consequently,  
increased formation of ROS and iv) the fact that the heart has low levels of 
antioxidant defenses when compared with other tissues (Lebrecht, Setzer et al. 
2003, Sardao, Pereira et al. 2008, Wallace 2003). 
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However, despite the clinical manifestations of DOX-induced cardiomyopathy 
and the knowledge that DOX induces several cardiac ultrastructural changes, 
the mechanisms responsible for DOX-induced cardiac toxicity remain elusive. 
Nevertheless, clinical manifestations of DOX-induced cardiotoxicity can be 
acute and chronic but there is a wide variation in the frequency of clinical DOX-
induced cardiotoxicity (Carvalho, Santos et al. 2009). Following some reports, 
acute effects in the heart, including arrhythmias, hypotension and several 
electrocardiographic alterations can be clinically controlled and frequently 
reversible, disappearing once the treatment ceases (van Acker, Kramer et al. 
1996). On the other hand, chronic cardiotoxic effects induced by DOX are dose-
dependent and culminate in CHF (Swain, Whaley et al. 2003). In both cases, 
mitochondria play an important role being classified as a primary target 
organelle of DOX-induced cardiotoxicity, evidenced by morphological and 
biochemical alterations. Interestingly, Hayward et al. (2012) suggested that all 
patients treated with anthracyclines are at greater risk of cardiotoxicity, 
particularly those individuals treated with these drugs at an early age. While it is 
still unclear why children are at a greater risk, it have been proposed that 
exposure to anthracyclines at a young age leads to chronically elevated 
hemodynamic stress and an eventual stunting of normal cardiac growth. Also, 
Huang et al. (2010) suggested that DOX exposure in juvenile rats decreased 
the ability of the heart to adapt to increases in workload as adults or olds.  
 
2.3.1 Cardiac mitochondrial toxicity induced by DOX 
Mitochondria are the producers of most of the ATP necessary for metabolism 
via oxidative phosphorylation. Also, they play other important roles as cellular 
redox and ion homeostasis, oxygen sensing, signaling and regulation of 
programmed cell death (for refs see Rabinovitch 2012, Sheu 2009). Therefore, 
mitochondrial integrity is vital for cellular homeostasis and cardiac performance 
(Chaudhary, El-Sikhry et al. 2011).  
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Unfortunately, mitochondria have been identified as primary DOX target 
organelles, and their involvement is evidenced by the results of many studies 
reporting functional and morphological alterations, as will be briefly described. 
Indeed, it has been suggested that cardiomyocyte dysfunction induced by DOX 
treatment is related to increased levels of ROS-induced damage and apoptotic 
cellular death, involving mitochondria in the process (Jung and Reszka 2001) 
culminating in the disruption of major functions (Jung and Reszka 2001). 
The next sections will briefly describe some DOX-induced mitochondrial 
dysfunctions such as morphological evidences, increased oxidative stress and 
susceptibility to apoptosis. 
 
2.3.1.1 Morphological evidences 
As a consequence of acute or chronic DOX treatment, ultrastructural alterations 
in rat cardiomyocytes have been reported (Ascensao, Ferreira et al. 2007, 
Ascensao, Oliveira et al. 2012, Yilmaz, Atessahin et al. 2006, Zhou, Starkov et 
al. 2001). These include nuclear swelling associated with disruption of nuclear 
membrane structure, a marked interstitial and cellular edema, perinuclear 
vacuolation, disorganization and degeneration of the myocardium, loss of 
myofibrils, distension of the sarcoplasmic reticulum, slight enlargement of the T-
tubules and myofibrillar damage and loss (for refs see Carvalho, Santos et al. 
2009, Zhou, Starkov et al. 2001).  Also, in mice cardiomyocytes, DOX-induced 
acute alterations in mitochondria were observed, such as vacuolization, myelin 
deposition, disruption of membrane and organelle degeneration with cristae 
degeneration, intramitochondrial vacuoles as well as myelin figures (Ascensao, 
Ferreira et al. 2007, Ascensao, Oliveira et al. 2012, Sardao, Oliveira et al. 
2009). 
These ultrastructural alterations are dose-dependent being that higher DOX 
concentrations promote more profound cellular alterations (Carvalho, Santos et 
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al. 2009) and those ultrastructural injuries are not repaired after cessation of 
DOX treatment becoming even more extensive.  
 
2.3.1.2 Increased oxidative stress 
One of the most known DOX-induced side effects is the increased oxidative 
stress and it seems to be an event that occurs both acutely and chronically 
(Ascensao, Oliveira et al. 2012, Wallace 2003). It has been suggested that DOX 
accumulation in mitochondria leads to a redox cycling by complex I of the 
mitochondrial respiratory chain, where single electrons are transferred to DOX 
(Ascensao, Oliveira et al. 2012). As previously mentioned, the possible but 
controversial existence of a specific NADH dehydrogenase able to start this 
redox cycling may have an important role. DOX enters mitochondria and reacts 
with mitochondrial complex I to form semiquinone radical intermediates, which 
is a short-lived metabolite and can react with O2 producing ROS (for refs see 
Carvalho, Santos et al. 2009). Then, ROS can react with mitochondrial 
biomolecules in the vicinity, which include lipids, proteins and nuclei acids. 
Furthermore, increased cardiac oxidative stress associated with DOX toxicity 
leads to the depletion of reducing equivalents, impairment in oxidative 
phosphorylation with consequent decline in ATP, and interference with cellular 
Ca2+ homeostasis (Wallace 2003). Also, DOX is known to react with 
mitochondrial mtDNA forming adducts that interfere with proteins expression, 
lipid oxidation and normal mitochondrial function, which in turn further increases 
ROS production (Sardao, Pereira et al. 2008). This “vicious cycle” postulated 
that accumulation of mtDNA mutations is exponential and associated with 
massive increase in ROS production (Lenaz 1998). As previously described, 
heart mitochondria are important target of DOX, accumulating the drug at 
relatively high concentrations. So, it is not surprising that these organelles are 
especially susceptible to DOX-induced oxidative damage, and at the same time, 
they are also important sources of DOX-induced ROS (Ascensao, Oliveira et al. 
2012). On other hand, studies show an upregulation of antioxidant defenses, 
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suggesting an adaptive response of cells to oxidative unbalance promoted by 
DOX (Yilmaz, Atessahin et al. 2006). Interestingly, the antioxidant capacity 
seems to increase significantly following DOX treatment in young but not in old 
Fischer suggesting an increase in DOX-induced oxidative damage with age 
(Pritsos and Ma 2000). Despite this fact, is notable that, although the heart has 
relatively low antioxidant capacity, it shows an upregulation as an adaptive 
response to this oxidative unbalance. Moreover, as a response to this cellular 
stress, HSP 60 and HSP 70 increased in hearts and mitochondria from DOX 
treated animals and cells (Ascensao, Magalhaes et al. 2005, Kavazis, Smuder 
et al. 2010).  
 
2.3.1.3 Increased susceptibility to apoptosis 
Another important DOX-induced alteration on cell is the increased susceptibility 
to trigger apoptosis. DOX toxicity leads to impairments on cellular Ca2+ 
homeostasis, which leads to increased susceptibility to the MPTP opening 
(Oliveira and Wallace 2006) that is characterized by the loss of the 
impermeability that characterizes the inner mitochondrial membrane, as it was 
previously described. This complex process is mediated by the formation and 
opening of protein complex-like pores, the MPTP (Ascensao, Lumini-Oliveira et 
al. 2011, Lumini-Oliveira, Magalhaes et al. 2011). As already mentioned, one of 
the consequences of the MPTP induction, besides the disturbance of cell and 
mitochondrial Ca2+ homeostasis, is the release of cytochrome c and some 
others pro-apoptotic proteins, with consequent initiation of apoptotic cascades. 
Also, the increased oxidative stress induced by DOX, is able to interfere with 
mitochondrial functionality, which leads to apoptosis. Indeed, DOX-induced 
cardiomyocytes apoptosis has been suggested to occur both acutely and 
chronically (Carvalho, Santos et al. 2009).  
As previously mentioned, its important to develop a strategy that results in a 
cardioprotective phenotype against DOX-induced impairments. In this regard, 
physical exercise in its various forms has been shown to be an effective 
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intervention that can counteract the acute and chronic deleterious insults for the 
myocardium, which includes DOX treatment. The following sections will briefly 
discuss this issue. 
 
2.4. Exercise as a therapeutic and preventive strategy against DOX-
induced cardiotoxicity. 
Exercise has been considered the most effective strategy to promote a healthy 
lifestyle and its benefits against DOX-related impairments are evident 
(Ascensao, Lumini-Oliveira et al. 2011, Ascensao, Magalhaes et al. 2005, 
Ascensao, Oliveira et al. 2012, Chicco, Schneider et al. 2005, Emter and 
Bowles 2008, Hayward, Lien et al. 2012, Kavazis, Smuder et al. 2010, Powers, 
Lennon et al. 2002, Wonders, Hydock et al. 2008). Although the most studied 
form of exercise in DOX treated animals is the chronic exercise, acute exercise 
also seems to provide beneficial effects. Mitochondrial adaptations may play 
critical role in exercise-induced protection against DOX-induced cardiac 
impairments (Ascensao, Ferreira et al. 2007, Ascensao, Oliveira et al. 2012). 
The effects of exercise on DOX-treated mitochondria are highlighted in table 2. 
 
2.4.1 Acute exercise 
Acute exercise broadly refers to a single bout of exercise performed only once 
and it was already proved to be effective against DOX-induced impairments. In 
fact, Wonders et al. (2008) reported that an acute bout of treadmill running 
performed 24 hours prior to DOX injection attenuated the hemodynamic 
impairment observed after acute DOX administration and reduced left 
ventricular lipid peroxidation. In addition, Ascensao et al. (2011) showed that an 
acute bout of treadmill exercise protects against cardiac mitochondrial 
dysfunction, preserving mitochondrial phosphorylation capacity and attenuating 
DOX-induced decreased tolerance to MPTP induction. In the same study, it was 
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observed that acute exercise prevented the decreased cardiac mitochondrial 
function detected as impaired state 3, phosphorylative lag-phase and maximal 
transmembrane potential. Also, acute exercise prevented the inhibitory effects 
of DOX treatment on the activity of cardiac mitochondrial respiratory chain 
complexes I and V, and on increased caspase-3 and -9 activities. 
Furthermore, it has also been described that acute exercise may contribute to 
diminished free radical production (for refs see Ascensao, Oliveira et al. 2012). 
However, further research is needed to clarify the exact mechanisms by which 
an acute exercise induces a protective phenotype in DOX-treated cardiac 
mitochondria. 
 
2.4.2 Chronic exercise 
Unlike acute exercise, chronic exercise has been hardly studied and the results 
consistently demonstrate that is able to antagonize DOX-induced cardiac 
impairments (Ascensao, Magalhaes et al. 2005, Chicco, Schneider et al. 2005, 
Hayward, Lien et al. 2012, Hydock, Lien et al. 2008, Kavazis, Smuder et al. 
2010). Those alterations induced by chronic exercise can be seen at 
morphological, functional and biochemical levels and the role of mitochondria is 
pivotal in this process (Ascensao, Oliveira et al. 2012, Kavazis, Smuder et al. 
2010). Ascensao et al. (2005) reported the involvement of mitochondria in 
cardioprotection afforded by endurance training against DOX treatment, 
demonstrating prevention of acute DOX-induced mitochondrial alterations 
regarding oxidative stress, respiration, and Ca2+ loading capacity.  
At ultrastructural level, it has been reported that cardiac alterations induced by 
DOX treatment are also attenuated by previous chronic exercise (Ascensao, 
Magalhaes et al. 2005). In fact, when compared with saline (SAL) group, 
sedentary (SED) DOX-treated animals showed myocardial damage (Ascensão, 
Magalhães et al. 2006). The observed morphological alterations consisted of 
mitochondrial damage with extensive degeneration and loss of cristae, swelling 
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and abnormal size and shape, intramitochondrial vacuoles and notorious myelin 
figures that probably resulted in the formation of secondary lysosomes. All of 
these alterations were attenuated in trained animals treated with DOX 
(Ascensão, Magalhães et al. 2006). 
At functional level, different authors reported the protective effects of chronic 
exercise. In fact, Hydock et al. (2008) suggested that exercise training in rats 
before DOX treatment attenuated DOX-induced cardiac dysfunction, through 
the maintenance of fractional shortening, developed pressure and contractility. 
Also, Chicco et al. (2005) reported that both low intensity exercise training and 
an endurance training protocol with gradually increased intensity attenuated the 
adverse effects of DOX by preventing DOX-induced decline in cardiac function 
through maintenance of left ventricular diastolic pressure, rate of left ventricular 
pressure development and rate of left ventricular relaxation. 
At biochemical level, as depicted on table 2, several authors had proved the 
beneficial effects of chronic exercise. Importantly, some of the most studied 
biochemical parameters associated with exercise and DOX are the antioxidant 
capacity, oxidative stress markers and apoptotic susceptibility (for refs see 
Ascensao, Oliveira et al. 2012). As previous referred, HSP have an important 
role as antioxidants molecules contributing to normal cellular integrity and are 
overexpressed after endurance training. However, Chicco et al (2006) and 
Kavasis et al. (2010) also showed that exercise had no influence on HSP or that 
it is not determinant on cardioprotection being that exercise in cold vs. normal 
temperatures may also display other types of differences regarding alteration of 
mitochondrial physiology, besides alteration in the expression of HSPs. 
Furthermore, the upregulation of mitochondrial manganese superoxide 
dismutase (MnSOD) seems contribute for cardioprotection. In fact, as 
mitochondrial DOX toxicity has been largely attributed to increased oxidative 
stress, increased antioxidant activity may be important to explain how 
endurance training counteracts some of DOX-induced myocardial damage. 
Chicco et al. (2006) associated low-intensity treadmill exercise training-induced 
cardioprotection to the inhibition of apoptotic signaling and the increased activity 
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of GPX. Also, the effect of training on preventing activation of cardiac apoptotic 
pathways has been described being that, training decreased the susceptibility of 
appearance of apoptotic markers in the hearts of DOX-treated animals, as 
increased mitochondrial Bax, Bax-to-Bcl2 ratio and tissue caspase 3 activity 
(Ascensao, Magalhaes et al. 2005). In fact, it has been suggested that chronic 
exercise stimulation may also afford protection against the increased 
susceptibility to the MPTP as the deleterious effects of Ca2+ on heart 
mitochondrial respiration of DOX-treated animals were attenuated in trained 
group treated with DOX (Ascensao, Magalhaes et al. 2005). As previous 
described, MPTP is related to oxidative damage and therefore, it is possible that 
increased resistance of cardiac mitochondria from trained animals to the MPTP 
can be related to increased antioxidant defenses. Accordingly, the higher levels 
of reduced sulfhydryl groups in trained mitochondria than in sedentary groups 
may be indicative of enhanced antioxidant capacity and/or of more elevated 
sulfhydryl-donors, such as GSH, in mitochondria from trained animals (for refs 
see Ascensao, Oliveira et al. 2012). However, further studies are necessary in 
order to better understand this issue. 
 
 
 
 
 
Table 2. Summary of some described mitochondrial-related alterations associated with 
DOX-induced cardiotoxicity and the modulation effect afforded by physical exercise 
against DOX (adapted from Ascensao, Oliveira et al. 2012). 
 DOX effect Exercise effect against DOX 
ROS production ↑ ↓ 
Oxidative damage markers   
Lipid peroxidation ↑ ↓ 
Protein oxidation ↑ ↓ 
DNA oxidation ↑  
Aconitase activity ↓ or = ↑ 
Apoptotic signaling   
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(↑) – increase; (↓) – decrease; (=) – no alterations 
 
Despite the extensive number of studies on this topic, the effects of both 
endurance treadmill training and voluntary free-wheel running activity performed 
Bax-Bcl-2 ratio ↑ ↓ 
Cytochrome c release ↑  
Caspase 9 activation ↑ ↓ 
Respiratory endpoints   
State 3 ↓ ↑ or = 
State 4 ↑ or = or ↓ = or ↓ 
RCR ↓ = or ↑ 
ADP/O ratio = or ↓  
Uncoupled respiration ↓ ↑ 
Creatine-stimulated respiration ↓  
Maximal ΔΨ ↓ or = ↑ 
Ca2+-induced MTPT ↑ ↓ 
ANT content and functioning ↓  
Mitochondrial chaperones ↑ ↑ 
Mitochondrial antioxidants   
Thiols ↓ ↑ 
Vitamin E ↓ or =  
Enzymes = or ↑ ↑ 
Coenzyme Q isoenzymes =  
ETC complex activity   
Complex I ↓ ↑ 
Complex II ↓  
Complex III =  
Complex IV = or ↓  
Complex V ↓ ↑ 
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before and during sub-chronic DOX treatment schedule on cardiac 
mitochondrial bioenergetics are yet to be elucidated. 
This is of particular importance in the context of exercise-induced protection 
against DOX-related cardiac mitochondriopathy, as cancer patients undergoing 
DOX treatment may be advised to exercise for many reasons including to 
counteract physical fatigue and to improve performance, and also to mitigate 
cardiac damage as a result of chemotherapy. 
This master sports science course in which this work is inserted is the context of 
physical activity and elderly. Despite developed with adult rats, the present work 
can contribute to extend the knowledge in this particular area representing 
preliminary findings in adult population and considering that DOX-based 
chemotherapeutic treatments against several types of malignances are more 
prevalent with increasing age. 
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3. Aim 
The aim of the present study was to analyze the effect of two types of physical 
exercise (treadmill endurance training (TM) and free-wheel voluntary physical 
activity (FW)) against heart mitochondrial dysfunction induced by sub-chronic 
treatment of DOX. 
 
We can define as specific purposes of this work the analysis of the adaptations 
induced by both types of exercise on heart mitochondria from DOX treated 
animals on: 
• Mitochondrial respiratory function; 
• Mitochondrial electrical transmembrane potential; 
• MPTP susceptibility; 
• Mitochondrial oxidative damage. 
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4. Materials and methods  
4.1 Reagents  
Deionized water (18.7 MΩ) from an arium®611VF system (Sartorius, Göttingen, 
Deutschland) was used. Doxorubicin hydrochloride, commercial/clinic use, was 
obtained from Ferrer Farma (Barcelona, Spain), prepared in a sterile saline 
solution, sodium chloride (NaCl) 0.9% (pH 3.0) and stored at 4ºC for no longer 
than five days upon rehydration. All other chemicals were purchased from 
Sigma Aldrich (Sintra, Portugal). 
 
4.2 Animals 
All experiments involving animals were conducted in accordance with the 
European Convention for the Protection of Vertebrate Animal Used for 
Experimental and Other Scientific Purposes (CETS no. 123 of 18 march 1986 
and 2005 revision) and the Commission Recommendation of 18 June 2007 on 
guidelines for the accommodation and care of animals used for experimental 
and other scientific purposes (C (2007) 2525). Supervisors of this work are 
accredited by the Federation of Laboratory Animal Science Associations 
(FELASA) for animal experimentation. The Ethics Committee of the Faculty of 
Sport approved this experimental protocol.  
Thirty-six male Sprague-Dawley rats (aged 2 weeks old) were obtained from 
Charles River Laboratories (L’Arbresle, France) and were randomly divided into 
six groups (n=6 per group): Saline sedentary (SAL+SED), saline treadmill 
endurance training (SAL+TM), saline free wheel voluntary physical activity 
(SAL+FW), doxorubicin sedentary (DOX+SED) doxorubicin treadmill endurance 
training (DOX+TM) and doxorubicin free wheel voluntary physical activity 
(DOX+FW). Only male rats were used to avoid hormone-dependent influence in 
drug mitochondrial function/toxicity. During the experimental protocol, animals 
were housed in collective cages (two rats per cage) and were maintained in a 
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room at normal atmosphere (21–22 ºC; 50–60% humidity) receiving food 
(Scientific Animal Food and Engineering, A04) and water ad libitum in 12-h 
light/dark cycles. 
 
4.3 Exercise protocols 
4.3.1 Endurance training protocol 
The animals from TM groups were exercised 5 days/week (Monday–Friday) in 
the morning (between 10:00 and 12:00 A.M.), for 12 weeks on a LE8700 motor 
driven treadmill (Panlab, Harvard, U.S.A). The treadmill speed was gradually 
increased over the course of the 12-week training period. The protocol included 
5 days of habituation to the treadmill with 10 min of running at 15 m/min, with 
daily increases of 5-10 minutes (min) until 30 min was achieved (week 0). 
Habituation was followed by one consecutive week of continuous running (30 
min/day) at 15 m/min and was gradually increased until 60 min/day on the week 
1. The velocity increased gradually from 18 m/min to 27 m/min (week 7). 
SAL+TM continue to increase velocity to 30 m/min while DOX+TM animals 
gradually decreased running velocity to 20 m/min (Table 3). 
 
Table 3. TM exercise protocol 
Week 0 1 2 3 4 5 6 7 8 9 10 11 12 
SAL+ TM  
TM Velocity (m/min) 
15 18 20 22 24 25 25 27 27 28 28 30 30 
DOX + TM  
TM Velocity (m/min) 
15 18 20 22 24 25 25 27 27 25 25 22 20 
Exercise Duration 
(min/day) 30 60 60 60 60 60 60 60 60 60 60 60 60 
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4.3.2 Voluntary physical activity 
The animals from FW groups were housed in a polyethylene cage equipped 
with a running wheel [perimeter=1,05m, Type 304 Stainless steel (2154F0106-
1284L0106) Technicplast, Casale Litta, Italy)]. The rats were allowed to 
exercise ad libitum with an unlimited access to the running wheel 24h/day. 
Running distance was recorded using ECO 701 from Hengstler (Lancashire, 
U.K.). 
 
4.4 Doxorubicin treatment 
After the 5th week of endurance training or free wheel exercise, the animals 
were sub-chronically treated with DOX (2 mg/Kg of body weight) or sterile saline 
solution NaCl 0.9% (SAL, 2 mg/kg of body weight) intraperitoneal injection/week 
during 7 weeks. The animals assigned to the TM groups received DOX or SAL 
injections during the weekend in a day-off training.  
 
4.5 Animal sacrifice, heart and soleus extraction  
Forty-eight hours after the last TM exercise bout, non-fasted rats were 
euthanized by cervical dislocation between 9:00 and 10:00 AM to eliminate 
possible effects due to diurnal variation. After quickly opening the chest cavity, 
rat hearts were rapidly excised, rinsed, carefully dried, and weighed. Right 
soleus muscle was also rapidly extracted and weighed. Portions of 
approximately 50 milligrams (mg) of one soleus muscle were homogenized in 
homogenization buffer (200 minimolar (mM) Tris, 137 mM NaCl, 0.2 mM EDTA, 
0.5 mM EGTA, 1% triton X-100, tissue: buffer ratio of 100 mg/mL, pH 7.4) using 
a Teflon pestle on a motor driven Potter-Elvehjem glass homogenizer at 0–4°C 
three to five times for 5 s at speed low setting, with a final burst at a higher 
speed setting. Homogenates were centrifuged (2 min at 3000 xg, 4°C, in order 
to eliminate cellular debris) and the resulting supernatants were stored at −80°C 
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for later determinations, as detailed bellow. Protein content from soleus 
homogenates were spectrophotometrically determined using the biuret method 
and bovine serum albumin as standard (Gornall, Bardawill et al. 1949). 
 
4.6 Isolation of heart mitochondria 
Heart mitochondria were daily prepared using conventional methods of 
differential centrifugation (Bhattacharya, Thakar et al. 1991) as follows. Briefly, 
the animals were sacrificed as stated above and the heart was immediately 
excised and finely minced in an ice-cold isolation medium containing 250 mM 
sucrose, 0.5 mM EGTA, 10 mM HEPES (pH 7.4), and 0.1% defatted bovine 
serum albumin (BSA, Sigma, cat. no. A-7030). The minced blood-free tissue 
was then resuspended in 40 mL of isolation medium containing 0,75 mg/mL 
protease subtilopeptidase A Type III (Sigma P-5380) and homogenized with a 
tightly fitted homogenizer (Teflon: glass pestle). The suspension was incubated 
for 1 min (4°C) and then re-homogenized. The homogenate was then 
centrifuged at 13,000 xg for 10 min. The supernatant was decanted and the 
pellet, essentially devoid of protease, was gently re-suspended with a loose-
fitting homogenizer. The suspension was centrifuged at 750 xg for 10 min and 
the resulting supernatant was centrifuged at 12,000 xg for 10 min. The pellet 
was re-suspended using a paintbrush and re-pellet at 12,000 xg for 10 min. 
EGTA and defatted BSA were omitted from the final washing medium. 
Mitochondrial protein content was determined by the Biuret method calibrated 
with BSA (Gornall, Bardawill et al. 1949). The isolation procedures were 
performed within approximately 1 h at 0–4°C. Aliquots of isolated mitochondria 
were separated and frozen at −80°C for later determination of oxidative 
damage. The remaining mitochondrial were used within 2–3 h after the excision 
of the heart and was maintained on ice (0–4 ºC) throughout this period. 
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4.7 Mitochondrial respiratory activity 
Mitochondrial respiratory function was measured polarographically at 30ºC 
using a Biological Oxygen Monitor System (Hansatech Instruments) and a 
Clarktype oxygen electrode (Hansatech DW1, Norfolk, UK). The reactions were 
conducted in a 0.75 mL closed, thermostatted and magnetically stirred glass 
chamber containing 0.5 mg/mL of mitochondrial protein in a respiration buffer 
containing 50 mM KCl, 130 mM sucrose, 2.5 mM KH2PO4, and 0.5 mM Hepes, 
pH 7.4. After 1-min equilibration period, mitochondrial respiration was initiated 
by adding glutamate/malate (G/M) to a final concentration of 5 and 2.5 mM, 
respectively. State 3 respiration was determined after adding ADP (150 nmol); 
state 4 was measured as the rate of oxygen consumption after ADP 
phosphorylation. The RCR (state 3/state 4) and the ADP/O (the number of nmol 
ADP phosphorylated by atom of oxygen consumed) ratios were calculated 
according to Estabrook (1967). 
 
4.8 Mitochondrial transmembrane electric potential 
Mitochondrial transmembrane electric potential (∆ψ) was monitored indirectly 
based on the activity of the lipophilic cation tetraphenylphosphonium (TPP+) 
using a TPP+ selective electrode prepared in our laboratory as previously 
described (Ascensao, Lumini-Oliveira et al. 2011). Reactions were carried out in 
1 mL of reaction buffer containing 50 mM KCl, 130 mM sucrose, 2.5 mM 
KH2PO4, and 0.5 mM Hepes, pH 7.4 supplemented with 3 µM TPP+ and 0.5 
mg/mL of mitochondrial protein. For the measurements of ∆ψ with complex I-
linked substrates, energization was carried out with G/M (5 mM and 2.5 mM, 
respectively) and ADP phosphorylation was achieved by adding 150 nmol ADP. 
The lag phase, which reflects the time needed to phosphorylate the added ADP, 
was also measured during experiments.  
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4.9 Mitochondrial osmotic swelling during MPTP induction 
Mitochondrial osmotic volume changes were followed by monitoring the classic 
decrease of absorbance at 540 nm with a Jasco V-630 spectrophotometer. 
Swelling amplitude and rate of decreased absorbance upon Ca2+ addition were 
considered as MPTP susceptibility indexes. The reaction was continuously 
stirred and the temperature was maintained at 25 ºC. The assays were 
performed in 1 ml of reaction medium containing 200 mM sucrose, 10 mM 
HEPES, 5 mM KH2PO4, 10 µM EGTA , pH 7.4, supplemented with 1.5 µM 
rotenone, 8 mM succinate and a single pulse of 80 nmol of Ca2+ with 0.5 mg/ml 
protein. Control trials were performed by using 1 µM of cyclosporin-A, the 
selective MPTP inhibitor (Broekemeier, Dempsey et al. 1989). 
 
4.10 Mitochondrial oxidative damage  
Before analysis, mitochondrial membranes were disrupted by several freeze–
thawing cycles to allow free access to substrates. The extent of lipid 
peroxidation in heart mitochondria was determined by measuring MDA contents 
by colorimetric assay, according to a modified procedure described previously 
(Buege and Aust 1978). Suspended mitochondria were centrifuged at 12,000 xg 
for 10 min and re-suspended in 150 µL of a medium containing 175 mM KCl 
and 10 mM Tris-HCl, pH 7.4. Subsequently, mitochondria from the six groups 
were mixed with 2 volumes of trichloroacetic acid (10%) and 2 volumes of 
thiobarbituric acid (1%). The mixtures were heated at 80–90 ºC for 10 min and 
re-cooled in ice for 10 min before centrifugation (4,000 xg for 10 min). The 
supernatants were collected and the absorbance measured at 535 nm. The 
amount of MDA content formed was expressed as nanomoles of MDA per 
milligram of protein (ε535=1.56 x 10−5 M−1 cm−1) 
The basal mitochondrial content of oxidative modified -SH groups, including 
GSH and other -SH containing proteins, was quantified by spectrophotometric 
measurement according to Hu (1990). Briefly, a mitochondrial suspension 
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containing 5 mg/mL protein was mixed with 0.25 M Tris buffer pH 8.2 and 10 
mM DTNB and the volume was adjusted to 1 mL with absolute methanol. 
Subsequently, the samples were incubated for 30 min in the dark at room 
temperature and centrifuged at 3000 xg for 10 min. The colorimetric assay of 
supernatant was performed at 414 nm against a blank test. Total -SH content 
was expressed in nanomoles per milligrams of mitochondrial protein (ε414=13.6 
mM−1 cm−1). 
 
4.11 Soleus citrate synthase activity 
Soleus CS activity was measured using the method proposed by Coore et al. 
(1971). The principle of assay was to initiate the reaction of acetyl-CoA with 
oxaloacetate and link the release of CoA-SH to 5,5-dithiobis (2-nitrobenzoate) 
at 412 nm. 
 
4.12 Statistical analysis  
All data are expressed as the mean±SEM (Standard Error of the Mean). 
Statistical analyses were performed using GraphPad Prism (version 6.0) or 
Statistical Package for the Social Sciences (SPSS version 21.0). Three-way 
repeated-measures ANOVA for body weight and distance cover by exercised 
groups to verify the effect of exercise and treatment over time. Two-way 
analysis of variance ANOVA were used to examine possible effect of treatment 
and/or exercise. To determine specific group differences, the two-way ANOVA 
were followed by Bonferroni post-hoc tests. In all cases, the significance level 
was set at p≤0.05. 
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5. Results 
5.1. Characterization of animals and exercise protocols 
Body weight alterations and distances covered by the animals during the entire 
protocol are shown in figure 3. No significant differences in the mean body 
weight of the animals from the beginning of the protocol until the 5th week, when 
sub-chronical DOX treatment was initiated, were found. Body weights of DOX 
treated animals were lower than SAL counterparts at the end of the protocol 
(DOX+SED vs. SAL+SED; DOX+TM vs. SAL+TM; DOX+FW vs. SAL+FW; 
p≤0.05). No differences in body weight between exercised groups, were found. 
TM and FW decreased body weight at 12th and 9th week, respectively (SAL+TM 
and SAL+FW vs. SAL+SED; p≤0.05). DOX treatment combined with TM 
decreased body weight from the 5th week (DOX+TM vs. DOX+SED; p≤0.05), 
whereas no significant differences were found between FW and SED treated 
groups (Figure 3A). After the 5th week DOX treated groups consumed less food 
than their SAL counterparts (data non shown, p≤0.05). Water consumption 
increased in FW groups (SAL and DOX) compared with SAL+SED and 
DOX+SED groups (data non shown, p≤0.05). 
 
Figure 3. Effect of exercise and DOX treatment on (A) body mass over time and (B) 
distance covered per day by TM and FW groups during the 12 wks of protocol. 
Significant differences (p≤0.05) are mentioned in the text. Significant (p≤0.05) effects of 
Exercise (E), Treatment (T), time (t) or their interaction (E x T x t) are shown; Non 
Significant (NS, p>0.05).  
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As can be seen in Figure 3B, voluntary running distance decreased significantly 
in DOX+FW after the 5th week and remained lower until the end of the protocol 
(p≤0.05). Animals from TM group ran at the same velocity throughout the 8 
weeks of the protocol. Running velocity and distance covered diminished in 
DOX+TM group at 11th and 12th week compared to SED+TM (p≤0.05).  
Body, heart absolute weights, heart weight and femur length to body weight 
ratios, mitochondrial protein yielding as well as the activity of soleus citrate 
synthase in the six groups are shown in Table 4. Final body, heart weight and 
ratio of heart weight to body weight significantly decreased with DOX treatment 
(SAL+SED vs DOX+SED). Both chronic exercise types decreased final body 
weight, increased heart weight and the heart to body ratio (SAL+TM and 
SAL+FW vs SAL+SED). DOX treatment combined with TM and FW exercise 
induced a significant increase in heart weight and heart weight to body weight 
ratio compared with their DOX+SED counterparts. No significant differences 
were observed between groups regarding the Initial body weight, femur length 
to body weight ratio and yield of mitochondria isolation. TM induced a significant 
increase in the activity of soleus citrate synthase in both SAL and DOX treated 
animals (SAL+SED vs SAL+TM and DOX+SED vs DOX+TM). 
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Table 4. Animal data and yield of mitochondrial protein isolation  
 SAL+SED SAL+TM SAL+FW DOX+SED DOX+TM DOX+FW P* 
Initial body weight (g) 207±3.91a 214±3.76a 212±1.55a 209±4.68a 207±4.63a 209±2.60a NS 
Final body weight (g) 598±10.58a  522±9.87b  498±5.98b  438±6.22c  426±10.79c  429±16.95c  ExT  
Heart weight (g) 1.44±0.03a  1.92±0.08b 1.85±0.10b 1.10±0.03c 1.45±0.05a 1.55±0.11a E, T  
Heart weight/body weight 
(mg.g−1) 2.32±0.08
a  3.53±0.10bc 3.68±0.12c 2.62±0.11d 3.34±0.08b 3.34±0.12b  ExT  
Femur length/body 
weight (mm.g-1) 0.08±0.00
a 0.08±0.00a 0.09±0.00a 0.08±0.01a 0.09±0.00a 0.09±0.00a E, T 
Mitochondrial protein 
yielding  
(mg protein/g tissue) 
18.58±0.62a  15.15±1.22a  15.01±1.50a  16.96±0.83a  18.60±4.68a  17.84±1.57a  NS  
soleus citrate synthase 
activity (nmol. min-1.mg-1) 10.94±2.07
a 23.34±1.79b 11.22±2.65a 8.69±1.15a 22.22±1.97b 10.27±1.32a E, T 
Values (mean ± SEM). Different letters are significantly different (p≤0.05). * Significant 
(p≤0.05) effects of Exercise (E), Treatment (T), or their interaction (E x T) are shown; 
Non Significant (NS, p> 0.05). 
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5.2 Heart mitochondrial oxygen consumption  
Mitochondrial respiratory activity in both SAL and DOX treated groups was 
measured to identify exercise-dependent effects (Figure 4). DOX treatment 
decreased heart mitochondrial respiration during state 3 and increased state 4 
in SED animals (DOX+SED vs SAL+SED). Importantly, TM and FW exercise 
per se increased State 3 respiration in both SAL and DOX (SAL+TM and 
SAL+FW vs. SAL+DOX; DOX+TM and DOX+FW vs. DOX+SED). The coupling 
between oxygen consumption and ADP phosphorylation (RCR) was 
significantly affected by DOX treatment (DOX+SED vs. SAL+SED). TM 
significantly increased RCR in both SAL and DOX groups (SAL+TM vs. 
SAL+SED; DOX+TM vs. DOX+SED). FW increased RCR in DOX treated 
animals (DOX+FW vs. DOX+SED). Also, both TM and FW increased ADP/O in 
DOX group (DOX+SED vs. DOX+TM and DOX+FW). 
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Figure 4. Effect of exercise and DOX treatment on (A) state 3 of heart mitochondrial 
respiration, (B) state 4 of heart mitochondria respiration, (C) RCR and (D) ADP/O. Data 
are means±SEM for heart mitochondria (0.5 mg/mL protein) obtained from different 
mitochondrial preparations for each experimental group. Oxidative phosphorylation was 
measured polarographically at 30ºC in a total volume of 0.75 mL. Respiration medium 
and other experimental details are provided in methods. RCR, respiratory control ratio 
(state 3/state 4); ADP/O, number of nmol ADP phosphorylated by atom of oxygen 
consumed. Different letters are significantly different (P≤0.05). Significant (p≤0.05) 
effects of Exercise (E), Treatment (T), or their interaction (E x T) are shown; Non 
Significant (NS, p>0.05). 
 
5.3 Heart mitochondrial transmembrane electric potential 
Heart mitochondrial variations in maximal ∆ψ and during ADP phosphorylation 
were determined using G/M as substrates. DOX treatment significantly affected 
the maximal ∆ψ, repolarization and ADP lag-phase (Figure 5). FW but not TM, 
increased maximal ∆ψ and repolarization, whereas both types of exercise 
decreased the ADP lag phase (SAL+TM and SAL+FW vs. SAL+SED). Both 
exercise protocols were able to counteract the DOX harmful effect normalizing 
maximal ∆ψ, repolarization and ADP lag phase.  
52 
 
Figure 5. Effect of exercise and DOX treatment on heart mitochondria ∆ψ fluctuations 
(A) maximal energization, (B) ADP-induced depolarization, (C) repolarization and (D) 
ADP phosphorylation lag phase. Data are mean±SEM for heart mitochondria (0.5 
mg/mL protein) obtained from different mitochondrial preparations for each 
experimental group. Figure shows the average response of maximal mitochondrial 
membrane potential developed with glutamate (5 mM) plus malate (2.5 mM), the 
decrease in membrane potential after ADP addition (depolarization), the repolarization 
value after ADP phosphorylation, and the lag phase. Mitochondrial transmembrane 
potential was measured using a TPP+-selective electrode at 30ºC in a total volume of 1 
mL. Reaction medium and other experimental details are provided in methods. 
Different letters are significantly different (p≤0.05). * Significant (p≤0.05) effects of 
Exercise (E), Treatment (T), or their interaction (E x T) are shown; Non Significant (NS, 
p>0.05) 
 
5.4 Mitochondrial osmotic swelling during MPTP induction 
The effects of both types of exercise training and DOX treatment on in vitro 
susceptibility to Ca2+-induced MPTP opening were investigated. The addition of 
Ca2+ on mitochondria suspension resulted in a decrease in absorbance with 
three distinct phases. Initially, an increase in absorbance was observed, which 
most likely results from the formation of opaque Ca2+ crystals inside 
mitochondria (Andreyev, Fahy et al. 1998). Upon MPTP opening, a decrease of 
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absorbance with a slow followed by a fast kinetic rate is usually observed in 
cardiac mitochondria. Incubation of mitochondrial suspension with cyclosporine 
A, a specific MPTP inhibitor (Broekemeier, Dempsey et al. 1989), limits the 
absorbance decrease after Ca2+ addition, which demonstrate the association 
with MPTP opening. 
Figure 6 shows different end-points measured from the recordings obtained, 
namely (A) swelling amplitude (the difference between the initial and the final 
absorbance value) and (B) the average swelling rate. The results demonstrate 
that DOX treatment significantly increased susceptibility to Ca2+-induced MPTP 
opening (DOX + SED vs. SAL + SED). Heart mitochondria isolated from 
SAL+TM group, but not SAL+FW were less susceptible to Ca2+-induced MPTP 
opening (SAL + TM vs. SAL + SED). Both types of exercise were able to 
mitigate DOX-induced increased susceptibility to MPTP opening (DOX + TM 
and DOX + FW vs. DOX + SED). 
Figure 6. Effect of exercise and DOX treatment on heart mitochondria to Ca2+-induced 
MPTP (A) Swelling amplitude; (B) Average swelling rate. Data are mean ± SEM. The 
absorbance of mitochondrial suspension was followed at 540 nm. Mitochondria were 
incubated as described in methods. A 80 nmol of Ca2+ pulse (160 nmol/mg protein) 
was added to 0.5 mg of mitochondrial protein in order to attain the cyclosporin A-
sensitive swelling, indicating that the decreased optical density corresponding to the 
increased swelling was due to MPTP opening. Different letters are significantly different 
(p≤0.05). * Significant (p≤0.05) effects of Exercise (E), Treatment (T), or their 
interaction (E x T) are shown; Non Significant (NS, p>0.05) 
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5.5 Oxidative stress markers 
The next step was to ascertain whether exercise and DOX treatment-modulated 
mitochondrial oxidative stress markers. According to the protective phenotype 
seen in Fig.7 DOX treatment increased MDA levels and decreased –SH content 
(SAL + SED vs. DOX + SED). Exercise, particularly TM decreased 
mitochondrial MDA levels (SAL + TM vs. SAL + SED). Both types of exercise 
were able to revert DOX-induced alterations in MDA level and –SH content 
(DOX + SAL vs. DOX + TM and DOX + FW). 
Figure 7. Heart mitochondrial (A) MDA and (B) reduced sulfhydryl contents. Data are 
means±SEM for heart mitochondria obtained from different mitochondrial preparations 
for each experimental group. Different letters are significantly different (p≤0.05). 
Significant (p<0.05) effects of Exercise (E), Treatment (T), or their interaction (E x T) 
are shown; Non Significant (NS, p> 0.05). 
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6. Discussion 
The current study provided additional support to understand the effects of both 
endurance treadmill training and voluntary wheel running activity performed 
before, during and after sub-chronic DOX treatment schedule on cardiac 
mitochondrial bioenergetics. Only male rats were used to avoid hormone-
dependent influence in drug-induced mitochondrial toxicity (Lagranha, 
Deschamps et al. 2010). Rats were sub-chronically treated with DOX in an 
attempt to mimic human’s treatment, a protocol previously used by others 
(Pereira, Pereira et al. 2012, Santos, Moreno et al. 2002). Moreover, in the 
present study 1st DOX injection was administrated 5 weeks after the beginning 
of the exercise protocol with subsequent weekly injection until the end of 
protocol. This set up can be understood with both a preconditioning (preventive) 
and a therapeutic strategy against DOX treatment schedules. Two different 
types of exercise were analyzed: voluntary free wheel run and treadmill run. 
Considerable attention has been focused on the efficacy of exercise protocols 
since it has been speculated that further stress induced by exercise could be 
potentially detrimental, exacerbating the impairments induced by DOX (Emter 
and Bowles 2008). In fact, patients undergoing chemotherapy experience 
severe fatigue or exercise intolerance. Consequently, the intensity and duration 
of exercise they are able to tolerate is likely to be severely limited (Emter and 
Bowles 2008). For these reason, and because we wanted to analyze the 
response on heart mitochondria of DOX treated rats at distinct intensity and 
duration, both free wheel and run treadmill were performed. 
The results on mitochondrial function obtained in the present study confirm at 
least in part, the cardiac protection afforded by both endurance treadmill training 
and voluntary free wheel running (for refs see Ascensao, Oliveira et al. 2012) 
against DOX toxicity. Cardiac dysfunction and defective mitochondrial function 
in DOX-treated animals has been studied previously (Ascensao, Lumini-Oliveira 
et al. 2011, Ascensão, Magalhães et al. 2006, Chicco, Schneider et al. 2005, 
Kavazis, Smuder et al. 2010, Sardao, Pereira et al. 2008, Wallace 2003). The 
present study confirmed that sub-chronic DOX administration in heart 
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mitochondria results in: (i) worsening heart mitochondrial respiration; (ii) 
decreased maximally developed ΔΨ, repolarization and increased 
phosphorylative lag phase; (iii) decreased ability of heart mitochondria to 
accumulate Ca2+ before MPTP induction and (iv) increased MDA levels and 
decreased -SH content. Both types of exercise performed before and during 
DOX treatment resulted in attenuation or complete prevention of the heart 
mitochondrial impairments induced by DOX.  
 
6.1 Heart mitochondrial oxygen consumption and transmembrane 
electric potential  
Previous studies have shown that exercise attenuates DOX-induced cardiac 
damage, diminishing the increased biochemical and morphological signs of 
toxicity induced (Ascensao, Magalhaes et al. 2005, Ascensao, Oliveira et al. 
2012, Chicco, Schneider et al. 2006, Hydock, Lien et al. 2008, Kanter, Hamlin et 
al. 1985, Kavazis, Smuder et al. 2010); however, no data are available 
concerning the cross-tolerance effect of both voluntary free wheel running and 
endurance training on sub-chronic DOX treatment mitochondrial malfunction. 
Present results demonstrate that sub-chronic treatment of DOX induces 
impairments on mitochondrial respiration, and that 12 weeks of endurance 
running training and voluntary free wheel running prevented the inhibition of 
mitochondrial respiration. Alterations in mitochondrial oxidative phosphorylation 
induced by DOX relies in several factors including the decreased aconitase 
activity; increased ROS production and activity; and the decreased activity, 
content or organization of the electron transport chain complexes or proteins of 
the phosphorylation system (Ascensao, Lumini-Oliveira et al. 2011). Also, the 
depressed activity of mitochondrial complexes I and II caused by DOX (Santos, 
Moreno et al. 2002) could partially justify the diminished electron transport 
through electron transport chain (ETC) in the SAL+DOX group. Thus, the 
unaltered state 3 respiration observed in exercised groups suggest that, among 
other possible effects, training probably prevented the inactivation of complex I 
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and II in DOX-treated heart mitochondria. The enhanced ETC functionality 
could also be due to an up regulation of oxido-redutase activity or increased 
availability of reduced equivalents formation, consequently increasing the 
supply of electrons to the ETC (Nulton-Persson and Szweda 2001) or even to 
enhanced capability of phosphorylative system due an upregulation of Krebs 
cycle enzymes (Holloszy, Oscai et al. 1970). Furthermore, our experiments 
reveal that mitochondria isolated from hearts of animals treated with DOX 
exhibited impaired coupling (i.e., lower RCR). RCR is known as a respiratory 
parameter associated with mitochondrial functionality and structural integrity 
(Brand and Nicholls 2011). As exercise training prevent DOX-induced 
uncoupled cardiac mitochondrial respiration, this might suggest that exercise 
training enhance mitochondrial respiratory activity due increased 
phosphorilative system functionality. Interestingly, regarding RCR, FW running 
protocol was more effective at counteracting DOX-induced impairments, which 
may be consequence of a slight decreased in sate 4 observed in DOX+FW 
group. Concerning ADP/O, both TM and FW groups reverted the values of 
DOX+SED group, which suggest that training prevented the heart mitochondrial 
impairments in oxidative phosphorylation capacity in DOX rats.  
Because mitochondrial complexes rely on enzymatic machinery (Bernstein, 
Bucher et al. 1978), they can become prone to impairments induced by ROS, 
resulting in accumulation of products of protein oxidation. DOX-induced 
impairments in oxidative damage markers, such as MDA level and -SH content 
were consistent with alterations in mitochondrial respiratory function, which can 
suggest that exercise may counteract DOX-induced impairments in redox 
homeostasis. One possible justification for these alterations is that exercise 
induced up-regulation of mitochondrial defenses including HSPs or SOD 
contributing to the up-regulation of mitochondrial tolerance against DOX effects 
(Ascensao, Ferreira et al. 2007). The up-regulation of other antioxidants such 
as GSH and CAT has also been described with exercise and DOX (Ascensao, 
Magalhaes et al. 2005, Kavazis, Smuder et al. 2010).  
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The complementary study of Δψ is indispensable for a complete analysis of 
mitochondrial function being that it reflects the basic energetic relation to 
cellular homeostasis maintenance. In fact, the electrochemical gradient due the 
pumping of protons through the inner membrane (Murphy and Brand 1988) is 
indispensable to ADP phosphorylation (Stock, Leslie et al. 1999). Moreover, 
when cytosolic concentration of Ca2+ increases, mitochondria act as Ca2+ 
buffers due its ability to uptake and accumulate Ca2+ (Gunter, Yule et al. 2004). 
It has been suggested that intramitochondrial Ca2+ concentration, whose flow is 
directed in accordance with the protomotriz gradient, has a controlling function 
in metabolic rate of oxidative energy production through the activation of Ca2+-
sensitive dehydrogenases, F0F1ATPase and ANT (Glancy, Willis et al. 2013). 
Our results showed that DOX decreased maximal Δψ, repolarization and 
increased the lag phase. The lag phase represents the time elapsed to 
phosphorylate ADP. In the present study, exercise led to increased maximal 
Δψ, repolarization and decreased time to restore membrane potential after 
addition and consequent ADP phosphorylation in the DOX+FW and DOX+TM 
groups. One possible explanation for the observed protective effect of exercise 
may be associated with the preservation of mitochondrial complex activity, 
namely complex I and V in exercised groups (Ascensao, Lumini-Oliveira et al. 
2011). It is however important to note that the Δψ values above −200 mV in all 
experimental groups do not seem to compromise ATP synthase flow or the 
transport of ions and metabolites. In fact, the range of the Δψ is −120 to −220 
mV. For instance, regarding the driving force for ATP generation, it has been 
shown that the kinetics of the ATP synthase follow a sigmoid pattern in 
response to Δψ, reaching saturation at approximately − 100 mV (Kaim and 
Dimroth 1999). 
 
6.2. Mitochondrial osmotic swelling during MPTP induction  
In addition to their role in energy supply, mitochondria are also considered 
determinant players in the establishment of cytosolic Ca2+ homeostasis, 
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uptaking and accumulation of Ca2+ in the matrix, in a process that is favored by 
the electrochemical gradient formed across the inner mitochondrial membrane 
(Gustafsson and Gottlieb 2008). However, mitochondria have a finite capability 
to accumulate Ca2+ before undergoing Ca2+-dependent MPTP opening, and 
thereafter to the release of pro-apoptotic proteins, which in turn results in 
apoptosis (Ascensao, Lumini-Oliveira et al. 2011). In this regard, the study of 
exercise in the context of MPTP modulation may assume an important clinical 
relevance. Also, it has been described that, among others, a characteristic of 
MPTP after Δψ loss, is the increased osmotic swelling amplitude induced by 
Ca2+ in vitro (Gunter, Yule et al. 2004). Furthermore, endogenous Ca2+ levels in 
matrix are greatly higher in oxidative tissue, limiting heart ability to uptake Ca2+ 
before MPTP induction (Picard, Csukly et al. 2008). 
In the present study, only TM exercise per se was able to increase the 
mitochondrial capability to accumulate Ca2+ after MPTP induction. However, 
both protocols afforded protection against DOX impairments. Briefly, our results 
showed that DOX per se decreased the mitochondrial Ca2+ tolerance 
(SED+SAL vs. SED+DOX) and both exercise protocols counteract DOX-
induced impairments, possibly activating some defense mechanisms that might 
contribute to prevent the increased DOX-induced MPTP opening susceptibility 
(Marcil, Bourduas et al. 2006). 
As MPTP is known to be formed/regulated by several proteins including ANT, 
hexokinase VDAC, phosphate carrier or Cyp D (Ascensao, Lumini-Oliveira et al. 
2011, Crompton 1999, Halestrap and Brenner 2003), it is possible that exercise 
may positively modulate the expression and activity of those proteins. Also, 
given the refereed close relationship between increased mitochondrial oxidative 
stress and the susceptibility to MPTP induction (Kowaltowski, Castilho et al. 
2001), it is possible that the up-regulation and modulation of some mechanisms 
involving stress chaperones, as HSPs antioxidants or other defense systems 
(Ascensao, Ferreira et al. 2007), as well as the decreased heart mitochondrial 
free radical production found in rats undergoing regular exercise (Judge, Jang 
et al. 2005) may contribute to these protective effects. Moreover, the possible 
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increased functionality of the phosphorylative system in general, and the ETC in 
particular, induced by both exercise protocols may have some implications in 
Ca2+ uptake capacity. However, to better understand this phenomenon, further 
studies need to be addressed. 
 
6.3 Oxidative stress markers 
Prevailing hypotheses suggest that myocardial oxidative stress is a primary 
event in DOX-induced cardiotoxicity and it is believed to initiate several of the 
deleterious cellular events reported following DOX treatment (Zucchi and 
Danesi 2003). In fact, at present the principal mechanism of DOX-induced 
cardiotoxicity is believed to be increased mitochondrial oxidant production 
leading to protease activation and induction of apoptosis (Ascensão, Magalhães 
et al. 2006, Ascensao, Magalhaes et al. 2005, Chicco, Hydock et al. 2006, 
Chicco, Schneider et al. 2005). Accordingly, oxidative injury of fatty acids at 
subcellular level measured by increased levels of lipid peroxidation products 
has been frequently reported following DOX exposure (for refs see Chicco, 
Schneider et al. 2005). 
The present results show that TM, but not FW per se was able to decrease 
MDA level and increase -SH groups. In accordance to previous reports, DOX 
induced a significant decrease in -SH, indicating increased disulfide linkages 
from both proteins and GSH. As polyunsaturated fatty acids are considered 
highly susceptible to ROS attack, the increased oxidative stress caused by DOX 
led to peroxidative modification of lipid membranes affecting membrane integrity 
and permeability, which leads to decoupled mitochondria, altering normal 
mitochondrial respiratory function.  
Myocardial antioxidant enzymes defend the heart against the damaging effects 
of ROS and have been hypothesized to play an important role in exercise-
induced resistance to oxidative stress (Powers, Lennon et al. 2002) and in the 
attenuation of DOX cardiotoxicity (Singal, Iliskovic et al. 1997). In particular, 
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some studies suggested that the presence of myocardial SOD might be 
important for the prevention of DOX cardiotoxicity (Ascensao, Lumini-Oliveira et 
al. 2011, Sarvazyan, Askari et al. 1995, Yen, Oberley et al. 1996). This is 
reasonable, as SOD dismutates superoxide into H2O2, thereby providing the 
first line of defense against DOX-induced oxidative stress. Furthermore, 
increasing evidence suggest that myocardial HSP72 induction plays a pivotal 
role in exercise-induced cardioprotection against oxidative stress (Powers, 
Lennon et al. 2002, Powers, Locke et al. 2001, Taylor and Starnes 2003). 
 
6.4 Meaning for exercise-induced cardioprotection in aging 
Considering the present results in the context of exercise-induced 
cardioprotection in advanced age, they can be interpreted as preliminary. 
Indeed, it can be carefully speculated that the observed protective phenotype 
caused by both chronic models of exercise against DOX can also be observed 
in aged rats. In fact, Quindry et al. (2005) reported that aged rats submitted to 
exercise training ameliorate cardiac hemodynamic response with significant 
improvements in the apoptotic levels and signaling caused by IR injury. 
Furthermore, the authors observed that trained old rats increased MnSOD 
activity, which can be interpreted as a sign of cardiac mitochondrial adaptations 
induced by chronic exercise in old rats compared to their young counterparts. 
Similar results were found by Starnes et al. (2003), which suggest that, although 
observing cardioprotective protein phenotype alterations with age, exercise can 
enhance cardioprotection regardless of elderly. Furthermore, physical exercise 
has the ability to positively modulate some gene expression associated with 
improved heart function in aged rats. In fact, heart is known for its ability to 
produce energy from fatty acids because of its important β-oxidation equipment, 
which capacity is reduced with age (Starnes, Beyer et al. 1983). Confirming the 
potential beneficial effects of physical exercise on cardiac metabolism in elderly, 
Iemitsu et al. (2002) reported that exercise training improved the aging-induced 
decreased expression of peroxisome proliferator-activated receptor, which 
regulates genes related to fatty acid metabolism in the heart. Giving those 
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alterations reported in aged hearts, it is possible to speculate that the results of 
the present work could also be observed in aged rats; affording protection and 
mitigating the deleterious consequences associated with sub-chronic DOX 
treatment schedules. 
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 7. Conclusion  
In summary, the data from the present work provide additional support about 
the effect of two types of physical exercise (treadmill endurance training and 
free-wheel voluntary physical activity) against heart mitochondrial dysfunction 
induced by sub-chronic treatment of Doxorubicin (DOX). Our results showed us 
that: 
• Regarding mitochondrial respiratory function both types of exercise 
reverted the effects induced by DOX on state 3, RCR and ADP/O. 
Interestingly, free wheel voluntary physical activity was more efficient at 
counteracting DOX-induced defects on RCR; 
• Both types of exercise were able to counteract DOX-induced 
impairments in mitochondrial transmembrane endpoints. Importantly, free 
wheel voluntary physical activity was also more efficient at normalizing 
DOX-induced increases in lag phase; 
• Regarding mitochondrial osmotic swelling during MPTP induction, both 
exercise protocols reverted DOX-induced impairments. In fact, both 
types of exercise mitigated DOX-induced increases in swelling amplitude 
and average swelling rate. However, once again free wheel voluntary 
physical activity was more efficient at counteracting Ca2+-induced MPTP 
induction 
• Exercise protocols were able to revert DOX-induced increases in MDA 
content and decrease in sulfhydryl groups. 
The mechanisms by which treadmill endurance training and free-wheel 
voluntary physical activity seems to confer additional protection against DOX 
remain elusive and further studies need to be addressed in order to 
comprehend the role of the different systems, such as those related to 
mitochondria, in this process. 
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